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Coronavirus is a common etiologic agent of respiratory and enteric diseases in 
human and animals. Recently, a severe acute respiratory syndrome outbreak (SARS) in 
human was found to be caused by a new coronavirus, named SARS-CoV. It was 
suspected to have a natural reservoir host in animals. In fact, SARS-like coronaviruses 
were found in civets, ragoons and bats. Without vaccine and effecious treatment, SARS-
CoV has impacted heavily on economical and social activities. Therefore, it is important 
to understand what attribute to the jumping of SARS-CoV from animals to human in 
order to monitor the possible reemergence of the outbreak.  
Of isolated SARS-CoV and SARS-like coronaviruses, the most striking difference 
was found in the subgenomic mRNA 8. In human isolates collected at the late stage of 
the outbreak, subgenomic mRNA 8 of SARS-CoV was found with 29 nucleotide 
deletion. It resulted in the splitting of a single ORF (ORF8) into two ORFs (ORF 8a and 
8b). ORF 8a and 8b are predicted to encode two small proteins, 8a and 8b, and ORF 8 a 
single protein 8ab (a fused form of 8a and 8b proteins).  This deletion is hypothesized as 
the adaptation of SARS-CoV from animals to human. To understand the functions of 
these proteins, cDNA fragments covering these ORF were cloned into expression 
plasmids, and expressed in in vitro and in vivo systems.  It was shown that expression of 
a construct containing ORF 8a and 8b generated only a single protein 8a; no detection of 
the 8b expression was obtained. Expression of a construct containing ORF 8 generated 
the 8ab fusion protein. Subcellular localization studies of HeLa cells expressing protein 
8a, 8b and 8ab showed that 8a and 8ab are localized to the cytoplasm, and 8b in the ER.  
Site-directed mutagenesis and enzymatic treatment revealed that 8b and 8ab were 
 xiv
modified by N-linked glycoprotein and ubiquitination. More interestingly, the two 
proteins could form complex with ubiquitin and interferon regulatory factor 3, suggesting 




CHAPTER 1. LITERATURE REVIEW 
1.1. Classification of Coronaviruses 
Coronaviruses belong to one genus Coronavirus in the family Coronaviridae and 
are large, enveloped, positive and single stranded RNA viruses. They occupy the largest 
genome of all RNA viruses with a unique transcription mechanism (Lai and Cavanagh 
1997; Lai and Holmes 2001).  
Coronaviruses are known as a diverse group with a wide range of hosts from 
avian to mammalian species (Murray et.al.1992; Lai and Holmes 2001). On the basis of 
serological analysis and antibody cross-reactivity tests, coronaviruses were classified into 
three main groups (Table 1.1). 
  
1.2. Severe Acute Respiratory Syndrome (SARS) 
SARS is the first new infectious disease of this century and it spread globally 
within a few months (WHO report 2003).   
In late 2002, atypical pneumonia appeared in the province of Guangdong, in 
South China. It was initially reported with several hundred cases with unknown etiology. 
By March 2003, the disease had spread accidentally to Hong Kong, then to Singapore, 
and subsequently to Vietnam, Canada and United States by air travelers. The disease 
soon became a worldwide epidemic. By late April 2003, up to 25 countries were affected 
by the epidemic. With the efforts of governments, doctors and scientists, the epidemic 
was finally declined after 114 days. The total number of SARS patients worldwide was 
8098 with 774 deaths. Without vaccine and efficacious treatment, the disease affected a 
total of 29 countries with serious disruption to normal life. It almost paralyzed global  
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Human X    
TGEV, 
PRCoV 
Pig X X   
CCoV Dog  X   
FECoV Cat  X X X 
FIPV Cat X X   
I 
RbCoV Rabbit X X   
HCoV-
OC43 
Human X    
MHV Mouse X X X X 
SDAV Rat     
HEV Pig X X  X 
II 
BCoV Cow X X   
IBV Chicken X  X  III 
TCoV Turkey X X   
 
HCoV-229E, human respiratory coronavirus; TGEV, Porcine transmissible gastroenteritis virus;  
PRCoV, porcine respiratory coronavirus; CCoV, canine coronavirus; FECoV, heline enteric 
coronavirus; FIPV, feline infectious peritonitis virus; RbCoV, rabbit coronavirus; HCoV-OC43, 
human respiratory coronavirus; MHV, murine hepatitis virus; SDAV, sialodacryoadenitis virus; 
HEV, porcine hemagglutinating encephalomyelitis virus; BCoV, bovine coronavirus; IBV, avian 








economy with profound impact on tourism, education and employment (WHO report, 
2003).   
SARS is characterized with flu-like symptoms manifested with high fever 
exceeding 38°C, myalgia, dry nonproductive dyspnea, lymphopaenia, infiltrate on chest 
radiography and finally atypical pneumonia (Peiris et.al.2003 a and b). In March 2003, 
the etiologic agent of SARS was found to be a new coronavirus (SARS-CoV) (Drosten 
et.al., 2003; Fouchier et.al., 2003; Ksiazek et.al., 2003; Ksiazek et.al., 2003 Peiris et.al., 
2003 b).  
SARS is spread via droplets. However, the efficiency of infection is low with an 
infectivity index of about 3 (Lipsitch et.al., 2003). In some instances, a few patients were 
considered as super-spreaders by transmitting SARS-CoV to a large number of 
individuals (Riley et.al., 2003). Till now, there is no explanation for this phenomenon. 
The mortality rate of SARS is approximately 10%, but it also depends on the age group. 
The mortality rate is found low in children but was high in the elderly with up to 50% 
mortality rate (Stadler et al., 2003; Hon et.al., 2003). 
 
1.3. Virion morphology of SARS-CoV 
Like most coronaviruses, SARS-CoV appears, under electron microscopy, with a 
corona-like morphology (Fig. 1.1) (Stadler et al., 2003). The virus was observed with 
pleomorphic spherical particles of approximately 100nm in diameter (Marra et.al., 2003; 
Rota et.al., 2003). The viral envelope is prominently fringed and evenly dispersed with 
20 nm-long projectors; it is composed of a lipid bilayer, associated with M and E 
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proteins, and is also incorporated with S proteins (Rota et.al. 2003). The positive, single 
stranded RNA genome was integrated with the N protein within the envelope. 
 
Figure 1.1. a. Electron micrograph of SARS-CoV. b. Schematic diagram of SARS-CoV  Spike 
proteins (S: orange projectors) are radiated evenly on the lipid bilayer envelope. Together with S 
protein, membrane (M: blue) and envelope (E: pink) protein are associated with the lipid bilayer 
envelope. Nucleocapsid protein (N) integrated with viral RNA genome inside the viral envelope 
(Stadler et al., 2003). 
 
1.4. Classification of SARS-CoV 
 Classification of SARS-CoV was initially determined based on the identity of the 
most conserved proteins between coronavirus strains such as RdRp, helicase, 3C-like 
protease and structural proteins. Using unrooted phylogenetic analysis, Marra and Rota 
2003 simultaneously proposed that SARS-CoV represents a new group of coronavirus 
when they compared the sequence of the replicase proteins and the structural proteins of 
SARS-CoV to the other coronaviruses (Fig.1.2a). On the other hand, Snijer et.al., 2003 
used the rooted phylogenetic method and used the most conserved region encoded by 
ORF 1b as a criteria for comparison; they concluded that SARS-CoV is just an early split 
off from group 2 (Fig.1.2b). There is increasing evidence conceding SARS-CoV as a 
species of group 2 coronavirus. In fact, 80 percent of the whole SARS-CoV genome 









sequence is closely related to group 2 coronavirus genome sequences (Magiorkinis et.al., 
2004). However, SARS-CoV does not encode the hemaglutinin esterease, one of the 
conserved proteins in group 2 coronaviruses (Stadler et.al.2003).  
 
Figure 1.2. Phylogenetic analysis of Coronaviruses 
a. unrooted phylogentic tree (Marra. et. al., 2003) and b. rooted phylogenetic tree (Snijder et. al., 
2003) 
 
1.5. Genome organization of SARS-CoV 
 SARS-CoV contains a large RNA genome of 29,727 nucleotides excluding its 
poly (A) tail (Rota et.al., 2003; Marra et.al., 2003). The genomic RNA begins with a 
leader sequence (nucleotides 1 to 72) followed by 192 nucleotides of untranslated region 
(UTR). Downstream of the 5' UTR is two overlapping open reading frames (ORFs) 1a 
and 1b that occupy two-thirds of the genome and encode the two polyproteins 1a and 1ab 
(Marra et.al., 2003; Stadler et.al., 2003). The remaining part of the genome is covered by 
ORFs coding for other SARS-CoV proteins. The SARS-CoV genome contains with 14 
ORFs encoding structural proteins (S, E, M and N proteins) and accessory proteins 
(Marra et.al., 2003). Of these ORFs, ORFs 3a, 3b, 6, 7a, 7b, 8a, 8b and 9b of SARS-CoV 
 6
genome do not show any homology with other coronaviruses (Marra et.al., 2003; Rota 
et.al., 2003; Ziebuhr 2004). The SARS-CoV genome ends with a 340 nucleotide UTR 
and a poly (A) tail (Ziebuhr, 2004).  
 In SARS-CoV genome and at the upstream region of most ORFs, there is a 
typical sequence (5’ ACGAAAC 3’) that is considered as a transcription-regulatory 
sequence (TRS) (Marra et.al., 2003; Thiel et.al., 2003). The TRS of SARS-CoV was 
determined by aligning manually the upstream region of potential initiating methionine 
codons (Sawicki et.al., 1998). Together with the leader sequence, the 5' and 3' UTR, TRS 
directs the transcription and translation of coronavirus (Lai and Cavanagh, 1997; Stadler 
et.al., 2003). The schematic representation of SARS-CoV genome is summarized in 
Fig.1.3.  
 
1.6. Structure of subgenomic mRNAs and negative strand RNA of SARS-CoV 
One of the most distinct features of coronaviruses is the synthesis of different 
species of subgenomic mRNA with 3’ co-terminal, nested-set structure. All the 
subgenomic mRNAs start with the same sequence at the 3’ terminus and extend to 
various distances toward the 5’ end. Most of the genomic mRNAs of coronaviruses are 
structurally polycistronic but only the 5’ most ORF of each subgenomic can be translated 
(Lai and Cavanagh, 1997). However, in some cases, one mRNA can encode several 
proteins. For example, sugenomic mRNA3 of Infectious Bronchitis Virus (IBV) encodes 

































































































































































































































































SARS-CoV synthesizes nine species of subgenomic mRNAs (Fig.1.4) (Marra 
et.al., 2003; Rota et.at., 2003; Thiel et.al., 2003). The largest is the subgenomic mRNA 1 
with the size equivalent to the genomic RNA and the smallest is mRNA 9 containing 
only two overlapping ORFs. All structural proteins of SARS-CoV are synthesized from 
different subgenomic mRNAs and their ORFs are the 5' most ORF of the sequence. Some 
subgenomic mRNAs of SARS-CoV are predicted to code for multi-proteins. For 
example, the subgenomic mRNA 3 is predicted to encode protein 3a and 3b; the 
subgenomic mRNA 7 encodes protein 7a and 7b; the subgenomic mRNA 8 encodes 8a 
and 8b and the subgenomic mRNA 9 encodes N protein and protein 9b (Marra et.al., 
2003; Rota et.at., 2003; Ziebuhr, 2004).  
Another unique structure of coronaviruses is the presence of the leader sequence 
in all subgenomic mRNAs (Spaan et.al., 1983, Chang et.al., 1994). All the sugenomic 
mRNAs of coronaviruses are capped at the 5' terminus (Lai and Cavanagh, 1997). These 
two elements play important role in translation of subgenomic mRNAs by cap dependent 
mechanism. 
In SARS-CoV, the negative strand RNAs have complementary sequence with the 
sugenomic mRNAs and have sizes equivalent to each species of subgenomic mRNAs. It 
is believed now that negative strand RNAs are used as templates for synthesizing 
subgenomic mRNAs. 
 
1.7. Transcription mechanism of SARS-CoV 
 SARS-CoV shares the common transcription mechanism with other 
coronaviruses. In fact, the 3' UTR of SARS-CoV can act as a cis-acting element for 
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genomic replication in murine coronavirus (Goebel et.al., 2004). Transcription 
mechanism of coronaviruses followed a discontinuous mechanism and is directed by the 
5' leader sequence, the 5' UTR and 3' UTR (Raman and Brian, 2005; Zhang et.al., 2005). 
There are two models proposed for the discontinuous transcription mechanism of 




 One of the models relates to the priming of leader sequence. The leader sequence 
serves as primer for the synthesis of subgenomic mRNAs; the full-length negative strand 
RNA is used as a template to synthesize the different species of subgenomic mRNAs. 
The synthesized leader sequence was paired with the full-length negative strand RNA and 
initiates the transcription to synthesize subgenomic mRNAs. Subgenomic mRNAs in turn 
are used as the template to synthesize the negative strand RNAs (Lai and Cavanagh, 
1997).  
 
Figure 1.4. Diagram of subgennomic mRNAs of SARS-CoV 
Nine species of subgenomic mRNAs of SARS and their predicted encoded 
proteins are relatively descrided (Ziebuhr, 2004).  
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 The current model relates to the negative strand RNAs which are used as template 
for the synthesis of subgenomic RNAs (Schaad and Baric, 1994; Sawicki and Sawicki, 
1998; Marle et.al., 1999). In this mechanism, the synthesis of  each negative strand RNA 
species is separated into three steps (Sawicki and Sawicki, 1998). First, a complex forms 
between the 5' most TRS of the genome and the genomic 3’ end, initiating the generation 
of nascent negative strand RNA. Second, the complex scans through the genomic RNA 
and synthesizes the negative strand RNA. Finally, when the complex scans through a 
TRS on the genomic RNA, it may switches the template to the leader sequence of the 
genome to generate the complementary leader sequence and then release negative strand 
RNA. There is increasing evidence proving that the discontinuous transcription 
mechanism of coronaviruses is followed this model (Sawicki and Sawicki, 1990; Zuniga 
et.al., 2004).  
 
1.8. Translation mechanism of SARS-CoV 
The first two proteins synthesized are polyprotein 1a and 1ab (Ziebuhr et.al., 
2000). The translation of ORF1b is by a frameshifting mechanism (Brierley et.al., 1987 
Brierley et.al., 1989), resulting in the generation of the fusion polyprotein 1ab. 
Polyproteins 1a and 1ab are then cleaved by two viral proteases embedded in these two 
polyproteins. The released proteins assemble together with host proteins to form replicase 
complex to synthesize negative strand RNA and subgenomic mRNAs and genomic RNA 
(Ziebuhr et.al.,  2000).  
 Most SARS-CoV proteins are translated by a cap dependent translation 
mechanism. Leader sequence and the cap at the 5' terminus present at each subgenomic 
 11
mRNA can form complex binding to ribosome (Tahara et.al., 1994). Ribosome scans 
through subgenomic mRNA and starts translation at the first AUG encountered. 
Some SARS-CoV accessory proteins are translated from the polycistronic 
mRNAs. Mechanism of translation of these proteins has yet to be elucidated. For 
example, protein 3b is predicted to be generated by internal ribosomal entry mechanism. 
Protein 7b and 9b are predicted to be generated by a leaky scanning mechanism (Snijder 
et.al.2003). Generation of protein 8b is not clearly understood. 
 
1.9. Characterization of  SARS-CoV protein 
1.9.1. The polyprotein 1a and polyprotein 1ab 
The polyprotein 1a and 1ab of SARS-CoV are generated as precursor proteins and 
subsequently were cleaved into 16 small and functional proteins (Ziebuhr, 2004).   
 Unlike other coronaviruses with the presence of two papain-like proteases 
(PLpro) 1 and 2 in the polyproteins, SARS-CoV has only one single PLpro (Nsp 3). It 
cleaves the N proximal region of 1a and 1ab at 3 sites and releases non-structrual proteins 
(Nsp) 1 and 2 and itself from precursor polyproteins (Fig.1.3) (Thiel et.al., 2003; 
Harcourt et.al., 2004). PLpro may also have deubiquitin activity (Barretto et.al., 2005).  
Another protease also present in the SARS-CoV polyprotein is the 3C-like 
proteinase (Nsp 5) (Fan et.al., 2004), which is a well characterized and highly conserved 
protein in coronaviruses. It is responsible for the cleavage of the remaining part of the 
polyproteins at 11 sites from Nsp 4 to Nsp 16 (Fig.1.3) (Thiel et.al., 2003). RNA 
dependent RNA polymerase (RdRp) of SARS-CoV is Nsp 12 and helicase is Nsp13 
(Marra et.al., 2003; Rota et.al., 2003; Xu et.al., 2003). These two proteins are highly 
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conserved in coronaviruses and are used as criteria to construct the unrooted and rooted 
phylogenetic tree of SARS-CoV. Together with other cleavage products, RdRp and 
helicase proteins are essential for the replication and transcription of SARS-CoV.  
 Structural studies have shown that Nsp 8 is able to interact with both Nsp 7 and 
Nsp 9 (Zhai et.al., 2005). The super-complex forming between Nsp 7 and Nsp 8 interact 
with double strand RNAs and it encloses and stabilizes the RNA.  Nsp 9 has structure 
similar to two subdomains of the SARS-CoV 3C-like proteinase and is supposed to 
evolve from a protease. Nsp 9 alone is able to bind to RNA (Sutton et.al., 2004). These 
proteins together with RdRp and helicase therefore are predicted to involve in forming 
the replication and transcription machinery of SARS-CoV.  
 Nsp 10 interacts with the cellular oxido-reductase systems, causing extensive 
cythopathic effect (Li et.al., 2005c). Nsp 14, Nsp 15 and Nsp 16 are predicted 
functionally as the exonuclease, endoRNAse and mRNA cap-1 methyltransferase, 
respectively (Stadler et.al., 2003). However, their functions are not determined in 
infected cells.  The rest of Nsps are with unknown function at present. 
 
1.9.2. Characteristic of structural proteins of SARS-CoV 
1.9.2.1. Spike (S) protein 
S protein is one of the most well characterized proteins of SARS-CoV. It has a 
pental shaped structure, and is evenly projected on the lipid bilayer envelope, giving 
SARS-CoV a crown-like appearance. S protein is a class I fusion protein and is highly 
glycosylated with 23-predicted glycosylated sites (Bosch et.al.2003; Hofmann and 
Pohlmann 2004, Xiao et.al., 2003).  
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S protein is responsible for the binding of SARS-CoV to host cellular receptor. 
One of the well-defined receptors of SARS-CoV is a metallopeptidase, angiotensin-
converting enzyme 2 (ACE2) that is a carboxypeptidase functioning as a polypeptidase 
enzyme from the renal angiotensis system (Li et.al., 2003; Hofmann and Pohlmann, 
2004). ACE 2 is expressed in a variety of tissues and organs, permitting wide spread of 
SARS-CoV in human body (Li et.al., 2005b; Hofmann et.al., 2004). Another possible 
receptor reported to bind to the SARS-CoV S protein is the dendritic cell-specific ICAM-
grabbing non-integrin (DC-SIGN) protein which is found on dendritic cells (Yang et.al., 
2004). 
In other coronaviruses, S protein is cleaved into two domains S1 and S2 by the 
host cellular enzyme furin (Lai and Cavanagh, 1997). However, sequence alignment of 
murine hepatitis virus S protein with SARS-CoV showed the lack of essential residues 
for cleavage by furin. It is therefore likely that the SARS-CoV S protein is not cleaved 
into two domains by furin (Yao et.al., 2004). Based on its functional similarity to the S 
protein of other coronaviruses, SARS-CoV S protein is theoretically divided into two 
functional domains S1 and S2 (Li et.al., 2005b). 
The S1 region is composed of 600 amino acids ranging from residue 12 to- 612. It 
is functionally divided into N terminal domain (12-306) and ACE2-receptor binding 
domain (306-667) (Wong et.al.2004).  Structural studies showed that a gentle concave of 
an extended loop of S receptor binding domain cradles the N-terminal lobe of ACE 2 
(Prabakaran et.al., 2004; Kuba et.al., 2005). Fourteen residues of this loop interact with 
18 residues in ACE 2. Asparagine at position 479 and threonin at position 487 in S 
protein are two important residues involved in the specific binding to human ACE 2 (Li 
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et.al., 2005b). The receptor binding region of S1 (400-600) overlaps with a neutralizing 
epitope of S protein; and the neutralizing antibody against S protein blocks the binding of 
S protein to its receptor (Yi et.al., 2005; Chen et.al., 2005).  
The S2 region is from amino acid residue 667 to 1190 and functions as a fusion 
domain. It characterizes S proteins as class I fusion protein with a fusion peptide, two 
heptad regions and a transmembrane domain. The transmembrane domain anchors S 
protein on the viral envelope. Upon binding of S protein to ACE2, conformational change 
of the coil – coil structrure brings the virus membrane coming into close proximity to 
host cell membrane and simultaneously exposes fusion peptide to insert to host cell 
membrane triggering the fusion of two membranes (Ingallinella et.al., 2004; Tripet et.al., 
2005;). S protein of SARS-CoV mediate membrane fusion in means of pH-independence 
(Yang et.al., 2004)or dependence (Simmons et.al., 2004) leading to direct release of the 
genomic RNA into the cytoplasm of host cells (Zhang and Yap, 2004; Smith and 
Helenius, 2004) or direct the internalization of SARS-CoV using cellular endocytosis 
(Dimitrov, 2004).  Schematic diagram representing the domains of SARS-CoV S protein 






Figure1.5. Schematic diagram of S protein domain. 
NTD: N terminal domain. RDB: Receptor binding domain. RBM: Receptor binding motif. FP: 
Fusion peptides. HR-N: N and HR-C: Heptad repeated region.. TM: Transmembrane domain. IC: 
Intracellular domain (Li et.al., 2005b) 
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1.9.2.2. Envelope (E) and membrane (M) proteins 
E and M proteins are two major components of the virus envelope. Association of 
E protein and M protein is essential for the assembly of virus-like particles (VLPs). When 
coexpressed in cells, M and E protein of SARS-CoV were able to form sedimentable 
particles. Location of these two proteins in the ER, Golgi and intermediate compartments 
is essential for the assembly and secretory of virus particles through the secretory 
pathways of cells. The ratio of E and M required for virus-like particle formation is 1: 5 
(Huang et.al., 2004a; Ho et.al., 2004). 
M protein is a glycosylated protein comprising of 221 amino acids; it forms three 
transmembrane helices domain from residues 15 to 99, and 121 amino acid hydrophilic 
domain on the inside of virus particles (Marra et.al., 2003).  
E protein is indispensable in the assembly of VLPs. It is a small protein with 76 
amino acids. SARS-CoV E protein is less similar to other coronavirus envelope proteins 
(Aebely et.al., 2004).  
 
1.9.2.3. Nucleocapsid (N) protein 
SARS-CoV N protein consists of 422 amino acids and is minimally homologous 
to other coronavirus proteins. It is essential for the packing of RNA genome.  Two 
independent RNA binding domain of N protein are located at the N- and C-terminal 
regions of the protein. Deletion of these two domains diminishes RNA binding capability 
of N protein.  During packaging, N protein binds to specific RNA sequence of the 
genomic RNA located the 3' terminal region of ORF1b (Huang et.al., 2004b). 
 16
 N protein of SARS-CoV is localized mainly to the cytoplasm and some is found 
in the nucleus (You et.al., 2005; Rowland et.al., 2005). The protein is capable of forming 
dimers and high order multmers. A small ubiquitin-like modifier (SUMO) is reported to 
attach covalently to N protein at lysine residue 62 (Li et.al., 2005b). The binding of 
SUMO to N protein promotes homo-oligomerization of the protein. N protein is also 
reported to be cleaved by caspase 3; it induces T-cell response and it activates activator 
protein 1 signal transduction pathway. N is implicated to induce the host 
immunoresponse through the activation of nuclear factor kappa B (NFκB) protein (Tan 
et.al., 2005; Liao et.al., 2005) . 
 
1.9.3. Characteristics of SARS-CoV putative proteins 
 SARS-CoV encodes a unique set of ORFs which do not share with any of the 
known coronaviruses. They are ORF 3a, 3b, 6, 7a, 7b, 8a, 8b and 9b, which are predicted 
to encode accessory proteins of SARS-CoV. Among these SARS-CoV accessory 
proteins, protein 3a, 7a, 8a and 9b have been detected in patients sera (Guo et.al., 2004; 
Qiu et.al., 2005b; Tan et.al., 2004a).  
  In other coronaviruses, some subgroup-specific accessory proteins are 
dispensable for viral replication, at least in cell culture system. They may have important 
role in interaction between host and virus, thus contributing to viral fitness (Brown et.al., 
1995; Lai and Cavanagh, 1997).  
 Some of SARS-CoV accessory proteins have been characterized. One of the well 
characterized accessory proteins of SARS-CoV is protein 3a. It is encoded by ORF3a on 
subgenomic mRNA 3 and is the largest accessory protein of SARS-CoV. Expression of 
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protein 3a is detected in patients’ lung specimen as well (Yu et.al., 2004; Zeng et.al., 
2004; Tan et.al., 2005b). Protein 3a is located in the perinuclear region and Golgi 
apparatus and it interacts with structural proteins S, M and E (Qiu et.al., 2005; Yuan 
et.al., 2005a). In addition, it is transported to the surface of host cells and undergoes 
endocytosis (Tan et.al., 2004d). Protein 3a is found to stimulate the expression of 
fibrinogen (Tan et.al., 2005e). Protein 3a is proposed as a novel structural protein (Shen 
et.al., 2005) and is shown to induce apoptosis in Vero E6 cells (Law et.al., 2005).  
 Protein 3b of SARS-coV is also studied. It is encoded by ORF3b. Protein 3b is a 
154 amino acid protein and is localized to the nucleus (Yuan et.al., 2005c). It induces cell 
cycle arrest at G0/G1 phase (Yuan et.al., 2005b). The protein is predicted to be translated 
by an internal ribosomal entry mechanism.  (Siijder et.al.,  2004) 
Protein 7a is encoded by ORF7a of the subgenomic mRNA 7 and is composed of 
122 amino acids. It is likely a type I membrane protein (Nelson et.al., 2005; Bartlam 
et.al., 2005). Its C-terminal tail contains a typical ER retrieval motif. Protein 7a is located 
in the perinuclear region in SARS-CoV infected cells (Fielding et.al., 2004). 
Overexpression of the protein induces apoptosis in different cell lines via a caspase-
dependent pathway (Tan et.al., 2004c).  
Characteristics of the rest accessory proteins of SARS-CoV have not been 
elucidated yet. For example, protein 6 is predicted as a 63 amino acid protein encoded by 
the sugbenomic mRNA 6. It is predicted as a transmembrane protein of the viral envelope 
with N terminal outside of VLPs (Marra et.al., 2003). Protein 7b is predicted as a 44-
amino acid protein. It is encoded by ORF7b of the subgenomic mRNA 7 (Marra et.al., 
2003). 
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Protein 9b is downstream of N protein in subgenomic mRNA 9. It is 98-amino 
acid protein and is predicted to be expressed as leaky scanning of ribosome (Snijder 
et.al., 2003).  
 
1.9.4. The putative protein 8a, 8b and 8ab of subgenomic mRNA 8 of SARS-CoV 
Protein 8a and 8b are encoded by two overlapping ORFs (8a and 8b) of the 
subgenomic mRNA 8. In fact, the subgenomic mRNA 8 of most SARS-CoV strains 
collected from human isolates at the late stage of the outbreak is found with 29-
nucleotide deletions (between T27867 and A27868 for strain SG2774 (accession No: 
AY283798)) and two overlapping ORFs 8a/b (Marra et.al., 2003). In contrast, the 
subgenomic mRNA 8 of most SARS-CoV strains collected in animal and in human 
isolates at the early stages of epidemic and is found with a single ORF 8 (Guan et.al., 
2003). ORF 8 is predicted to encode a single protein 8ab, a fusion form of protein 8a and 
protein 8b. The deletion of 29 nucleotides and the formation of two ORFs of SARS-CoV 
are predicted as the adaptation of SARS-CoV from animals to human (Guan et.al., 2003; 
Poon et.al., 2004. Lau et.al., 2005;  Li. et.al., 2005). The schematic diagram of the 
SARS-CoV genome with and without the 29 nucleotides is described in Fig 1.6. 
ORF 8a and ORF 8ab are located immediate downstream of a strong TRS 
(AGUCUAAACGAAAUG) (Snijner et.al., 2003). Protein 8a contains 39 amino acids is 
predicted as a secretory protein containing a secretory signal sequence at the N-terminal 
region.  Protein 8ab consists of 122 amino acids (Marra et.al., 2003).  
Protein 8b consists of 84 amino acids. The splitting of ORF 8 into two 
overlapping ORF 8a/b due to the 29-nucleotide deletion makes it difficult to understand 
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the translation mechanism of ORF 8b. In fact, ORF 8b is located downstream of a weak 
TRS in the subgenomic mRNA 8a/b (CUAAUAAACUCAUG) (Marra et.al., 2003), but 
no additional sugenomic mRNA of SARS-CoV is found. Protein 8b and antibodies 
against this protein are not detected in infected patients. Protein 8b is predicted as a 
glycosylated protein (Rota et.al., 2003; Marra et.al., 2003; Guan et.al., 2003).  
The expression of these ORFs together with characteristics of proteins encoded by 
subgenomic mRNA 8 is presented in detail in chapter 3.  
 
Figure  1.6. Diagram of 29 nucleotide deletion of sugenomic mRNA 8 (Poon et.al., 2004). 
a. Genomic organization of SARS-CoV isolated from human and animal. ORF1a and ORF1b 
encode for polyprotein 1a and 1ab, followed by the regions encoding for structure protein S, E, M 
and N. These regions are illustrated in green boxes. 
b. Expanded view from nucleotide 27700 to 28200 of the SARS-CoV genomic sequence (based 
on AY278554 numbering). Putative ORFs in this region were indicated by brown boxes. The 
presence of 29-nucleotide sequence in ORF 8 from residue 27868 was described. Deletion of 29 
nucleotides results in the splitting of ORF 8 into two ORFs - ORF 8a and ORF 8b in human 




1.10. The life cycle of SARS-CoV  
The detailed life cycle of SARS-CoV has not been fully investigated. Generally, a 
coronavirus replication cycle comprises the following steps: viral attachment to host cell 
membrane receptor, penetration and uncoating of virus particles into cells, synthesis of 
genomic and subgenomic RNA, production of viral proteins in the cytoplasm, assembly 
in the ER and Golgi and release viral particles from cells (Lai and Canavagh, 1997; Lai 
and Holmes, 2001).  
Under microscope, SARS-CoV was observed to enter Vero E6 cells by membrane 
fusion between its envelope and host cellular membrane. The assembly of virion is 
started by the accumulation of RNPs in the swollen round ER and Golgi apparatus. 
Virions are released by smooth vesicles (Qinfen et.al., 2004). 
At the molecular level, SARS-CoV life cycle starts when the viral S protein 
interacts with host cell membrane receptors (Yang et.al., 2004), resulting in the release of 
viral genomic RNA. Once in the host cytoplasm, the RNA genome is translated by host 
translation mechanism to generate polyproteins 1a and 1ab. These polyproteins are 
cleaved by themselves into smaller proteins to form the special replicase machinery. This 
replicase machinery in turn synthesizes the genomic and negative strand RNA from 
genomic RNA templates. The subgenomic mRNA is synthesized from negative strand 
RNA. Through the transcription and translation of the subgenomic mRNAs, the structural 
proteins and other accessory proteins of SARS-CoV are synthesized.  
Currently, details of the assembly process of SARS-CoV is not clear. However, in 
MHV, the viral assembly started with package of the genomic RNA into nucleocapsid. 
Efficient package of SARS-CoV genomic RNA requires the specific RNA signal that is 
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predicted to consist of a 70-nucleotide stretch at the 3’ terminus of the ORF 1b (Huang 
et.al., 2004b). The N protein without the genomic RNA is unable to package into virions. 
Once the ribonucleocapsid is formed, it interacts with the M protein (Ho et.al., 2004). 
The interaction between M and ribonucleocapsid complex may lead to the formation of 
spherical internal core shell surrounding the ribonucleocapsid. Virus particle formation 
takes place at the ER or Golgi membrane where M and E protein are anchored (Ho et.al., 
2004; Nal et.al., 2005). Virion release is mediated by host secretory pathway.  
1.11. Scope of thesis  
SARS-CoV contains group-specific ORFs which are not homologous to any 
proteins from other coronaviruses. These ORFs all encode SARS-CoV accessory 
proteins. In other coronaviruses, accessory proteins are predicted to contribute to the 
fitness of virus to adapt to host. 
In SARS-CoV, the most striking difference is found with the 29-nucleotide 
deletion in the subgenomic mRNA8 of SARS-CoV isolated from human patients at the 
late stage of the outbreak. This deletion results in splitting of a single ORF (ORF 8) into 
two ORFs (ORF 8a and 8b) and is predicted to attribute to the adaptation of SARS-CoV 
from animals to human. 
 ORF 8a and 8b are predicted to encode two small proteins, 8a and 8b, and ORF 8 
a single protein 8ab (a fused form of 8a and 8b proteins).  To understand the functions of 
these proteins, cDNA fragments covering these ORFs were cloned into expression 
plasmids, and expressed in in vitro and in vivo systems.  It was shown that expression of 
a construct containing ORF 8a and 8b generated only a single protein 8a; no detection of 
the 8b expression was obtained.  Expression of a construct containing ORF 8 generated 
 22
the 8ab fusion protein.  Subcellular localization studies of HeLa cells expressing 8a, 8b 
and 8ab proteins showed that protein 8a and 8ab are localized to the cytoplasm and 
protein 8b in the ER.  Site-directed mutagenesis and enzymatic treatment revealed that 8b 
and 8ab were modified by N-linked glycoprotein, and by ubiquitination.  More 
interestingly, the two proteins could form complex with ubiquitin and interferon 
regulatory factor 3, suggesting the potential involvement of these protein in the 

































CHAPTER 2. GENERAL MATERIALS AND METHODS 
2.1 General materials 
2.1.1. Plasmids 
 Cloning plasmids used in this project:  
  pKT0 and pKT-Flag (Liu et.al.1994) contain T7 promoter. Protein expression 
using these constructs was dependent on the Vaccina/T7 system to provide the T7 
polymerase.  
 pXJ40 were made by  contains with human cytomegalovirus (CMV) IE promoter, 
and could be expressed in mammalian cells.  
 pGEX-5X-1 (Amersham) was used to express Gluthionine S-transferase (GST) 
fused protein  in Escherichia coli (E.coli). 
 p53 were cloned by Prof. David Lane' lab (IMCB). IκBα  were cloned by 
Dr.Vinay Tergaonkar's lab(IMCB). pMyc- Ubiquitin (pMyc - Ubi) were cloned by Dr. 
Daoxin Xie(IMCB). These three plasmids contain CMV IE promoters. 
 
2.1.2. Antibodies 
Primary antibodies: anti-Flag and anti-Myc monoclonal antibodies were from 
SIGMA; anti-IRF3 and anti-I kappa B alpha (IκBα) antibodies were from Santa Cruz; 
anti-p53 antibodies were from David Lane’s lab and anti-8b antibodies were raised in 
rabbits in our lab. 
Secondary antibodies: goat anti-mouse secondary antibodies conjugated with 
horseradish perosidase (HRP), and mouse anti-goat or anti-rabbit secondary antibodies 
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conjugated with HRP were purchased from DAKO. Goat anti-mouse or goat anti-rabit 
secondary antibodies conjugated with flourescein isothiocyanate were from Invitrogen. 
2.2. Cloning and DNA manipulation 
2.2.1. DNA plasmid purification 
2.2.1.1. Alkaline lysis for plasmid screening  
 Single colonies of bacteria were inoculated into 1.5 ml of Luria-Bertani [10 g 
tryptone, 5 g yeast extract and 10 g NaCl in 950 ml sterile water] with 1 μg/ml ampicillin 
(LB/ampicilin) and cultured at 37oC overnight. The culture was centrifuged at 13000 rpm 
at room temperature (RT) for 1 min. The supernatant was removed, and pellets were 
resuspended in 140 μl of Solution I [50 mM sucrose, 25 mM Tris-HCl (pH 8), 10 mM 
ethylene diamine tetra-acetic acid (EDTA)], followed by lysis with 140 µl of Solution II 
[200 mM NaOH, 1 % SDS] and then neutralized with 200 µl of Solution III [3 M 
MaOAc pH5.2]. Samples were centrifuged at 13000 rpm for 5 min. The supernatant was 
transferred to a tube containing 2 volume of absolute ethanol, followed by vortexing and 
incubation at RT for 10 min. The precipitated DNA was collected by centrifuging at 
maximum speed for 5 min and resuspended in 50 µl sterile water. 
 
2.2.1.2. Qiagen midipreps 
 A single colony was inoculated in 3 ml 1 X LB/ampicillin and cultured at 37oC 
overnight. DNA purification was performed according to the manufacturer's instructions. 




2.2.1.3. Promega midipreps 
 Five to eight colonies were inoculated in 50 ml LB/ampicillin.  Using the 
Promega midiprep kit, 120 – 180 μg of DNA was purified from 50 ml overnight bacterial 
culture according to the manufacturer's protocol. 
 
2.2.2. DNA concentration determination 
 Four micro-liters of DNA preparation were diluted 1:200 in distill water. 
Spectrophotometric readings of DNA at A260nm and A280nm were taken. One OD260nm is 
equivalent to 50 μg DNA per μl. The ratio A260nm to A280nm is used to determine DNA 
purity.  
 
2.2.3. Polymerase chain reaction (PCR) 
 Specific primers were designed manually. In each PCR reaction, appropriate 
primers and DNA templates were used together with Tag Pfu DNA polymerase 
(Fermentas). Components for 50µl reaction were mixed as follows:  
DNA template (0.2µg/µl)     0.5 µl 
NTPs (10 mM each of dATP, dGTP, dCTP, dTTP)  1 µl 
10 X Tag or Pfu DNA reaction buffer   5 µl 
Forward primer (10pmol/µl)     1 µl 
Reverse primer (10pmol/µl)     1 µl 
Tag polymerase or Pfu DNA polymerase (2U/µl)  2 µl 
Sterile water to final volume of 50 µl 
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 The PCR conditions were carried out at 95oC for 5 min, followed with 35 cycles 
of denaturing at 95oC for 45 sec, annealing at 50 – 55oC for 45 sec, elongation at 72oC for 
1 min and a final elongation 72oC for 10 min.  On completion of the PCR program, the 
samples were cooled to 16oC.   
 
2.2.4. Overlapping PCR 
 Overlapping PCR was used to get chimera PCR fragment using a two steps PCR 









 The overlapping PCR contained 2 set of primers as shown above. Primer 3 and 4 
were designed to have an overlapping chimera sequence. The first step involved two PCR 
reaction with a common template using two different sets of primers : primers 1/ 3 and 
primers 2/ 4. The second round used the two chimera overlapped PCR fragments as 
templates together with primers 1 and 2. The PCR conditions of each round were the 








Figure 2.1. Overlapping PCR  Legend 
Template 
Chimera overlapped PCR fragments 
            Chimera PCR product 
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2.2.5. Site-directed mutagenesis 
 A set of complementary primers bearing nucleotide mutations was designed to 
synthesize the mutant plasmid. PCR was performed with Pfu turbo polymerase 
(Stratagene). Components in each PCR reaction were mixed as in normal PCR. The PCR 
conditions were: 95oC for 5 min followed with 12 - 16 cycles of 95oC for 45 sec, 50 – 
55oC for 45 sec and 68oC for 3-5 min and cooled to 16oC.  The elongation times were 
adjusted accordingly to the length of plasmid DNA. 
 Fifty micro-liters of PCR samples were digested with 1 µl Dnp I (New England 
Biolabs). Subsequently, 1 µl of digested PCR samples was directly transformed into 
E.coli DH5α, spread onto 1.5 % agar LB/ampicilin plate and incubated at 37oC overnight.  
DNA plasmids were extracted using Qiagen midipreps. The correct plasmid was verified 
by automated sequencing with appropriate primers. 
 
2.2.6. Automated DNA sequencing 
  Two hundred nanograms DNA was added to a mixture containing 10 pmol of 
primer, 4 µl of big dye termination (ver. 3.1) reaction mix and sterile water in the 10µl 
reaction.  
 The sequencing conditions were 96oC for 10 sec, 50oC for 5 sec, and 65oC for 4 
min for 25 cycles and cooled to 16oC.  
 The sequenced product was then purified to remove any residual dye.  The 
sequenced product was precipitated with 80µl of 80% ethanol, vortexed briefly and 
incubated at room temperature for 20 min. The mixture was centrifuged at 13000 rpm for 
15 min. The supernatant was discarded and the pellet was washed with 150 µl of 70% 
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ethanol by centrifuging at 13000 rpm for 5 min. The supernatant was removed and the 
pellet was vacuum dried for 8 min. The sequence was determined on an Applied 
Biosystems Model 3730XL automatic DNA sequencer at the DNA Sequencing and 
Analysis Facility in (IMCB).  
 
2.2.7. Agarose gel electrophoresis and gel purification 
 One percent agarose gel was prepared by dissolving agarose powder (Invitrogen) 
in 1 X TAE (40 mM Tris-acetate, 1 mM EDTA) buffer and 0.5 μg/ml ethidium bromide 
(SIGMA).  The DNA samples were mixed with 6 times loading dye (0.25 % 
bromophenol blue, 0.2 5% xylene cyanol FF and 40 % sucrose in sterile water) in the 
ratio 5: 1 before loading into individual wells. The Gel was submerged in a running tank 
(Hybaid) of TAE buffer and run horizontally at 120 Volts (Hoeffer Scientific 
Instruments) at constant voltage. Nucleic acid bands separated on agarose gels were 
visualized by UV transillumination (BIORAD), and fragment sizes were compared with a 
1 kb ladder DNA marker (Gibco BRL). 
 For gel purification, upon separation and viewing, the desired band was excised.  
Purification of DNA fragment was achieved using Qiagen gel extraction kit according to 
manufacturer’s instructions. 
  
2.2.8. PCR Purification 




2.2.9. Restriction endonuclease digestion 
 Two micrograms of DNA plasmid or PCR fragment were mixed with 10 units of 
appropriate restriction enzymes (New England Biolabs or Promega) in a 25 μl of reaction 
buffer and digested for 1.5 hrs at the recommended temperature by the manufacturer.  For 
double digestion, the reaction was digested concurrently for 1.5 hrs at the manufacturer’s 
recommended temperature. 
 
 2.2.10. Dephosphorylation of vector 
 Dephosphorylation of digested plasmid was done with Calf intestinal phosphatase 
(CIP) from New England Biolabs.  Two smicrograms of digested plasmid DNA was 
mixed with 1 U of CIP in 50 μl reaction. After incubation at 37oC for 1 hr, the DNA was 
extracted by Qiagen PCR clean up kit. 
 
2.2.11. Ligation of DNA insert and vector 
 The Ligation was carried out in a 20 μl reaction. Purified, dephosphorylated 
vector and appropriate excised DNA insert were mixed in a ratio 1:3 in the presence of 1 
U of T4 DNA ligase (New England Biolabs) in recommended buffer. The mixture was 
incubated at 16oC overnight. 
 
2.3. Bacterial transformation 
2.3.1. Preparation of (E.coli) DH5α and BL21 competent cells for heat shock 
transformation 
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 A single colony of E.coli DH5α or BL21 from 1.5 % agar was inoculated in 5 
ml of liquid LB at 37oC overnight. Four micro-liters of overnight culture was inoculated 
into 200 ml of LB and incubated at 37oC until an OD660 of 0.6-0.8. The cells were cooled 
down on ice for 30min prior to centrifugation at 4000 rpm at 4oC for 15 min. The cells 
were resuspended in 40 ml of ice-cold 0.1 M CaCl2 and incubated on ice for 1 hr. After 
centrifugation, the cells were resuspended in 4 ml of ice-cold 0.1 M CaCl2 and 20 % 
glycerol.  The prepared competent cells were aliquoted into small vials and stored at -
80oC. 
 
2.3.2. Heat shock transformation 
 One hundred nanograms of plasmid DNA or 5 µl ligated DNA were added to 50 
µl of compatible competent cells, incubated on ice for 30 min, followed with incubation 
at 42oC for 2 min and then on ice for 5 min.  
 Transformed bacteria were directly spread on 1.5% agar, LB/ampicilin plate and 
incubated at 37oC overnight. 
 Bacteria transformed with ligated DNA were recovered by adding 1 ml of 2 X LB 
and incubated at 37oC for 1 hr. 100 µl of bacteria were then spread on 1.5 % LB agar 
with ampicilin plate and incubated at 37oC overnight. 
 
2.4. Transcription and translation 
2.4.1. Coupled in vitro transcription and translation 
 One microgram of plasmid DNA was mixed with TNT coupled wheat germ 
extracts or rabbit reticulocyte lysates in the presence of 35S methionine according to the 
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manufacturer's instruction. The mixture was incubated at 30oC for 90 min and used for 
subsequent experiments or kept at -20oC. 
 
2.4.2. Transient transfection of mammalian cells 
 Eighty to ninety percent of confluent monolayer of mammalian cells on 30-mm 
NUNC dishes was transfected with 4 μg of plasmid DNA using Lipofectamine 2000 
reagent (Invitrogen) according to the manufacturer's instruction. Cells were grown in 
serum and antibiotics-free DMEM and incubated at 37°C with 5 % CO2. After 4 to 6 hrs 
posttransfection, the medium was removed and replaced with fresh DMEM supplemented 
with 10 % FBS, 1 % ampicillin and 1 % streptomycin, and continuously incubated at 
37°C, 5% CO2 for 24 hrs. The cells were then washed once with sterile phosphate-buffer 
saline (PBS), harvested and kept at -20 oC until further analysis. 
 
2.4.3. Transient transfection of mammalian cells using a recombinant vaccinia 
virus/T7 expression system  
Eighty to ninety percent of confluent monolayer of mammalian cells on 30-mm 
NUNC dishes was infected with recombinant vaccinia virus that generated bacteriophage 
T7 RNA polymerase. After 4 hrs post-infection, the virus was removed.  Cells were 
washed once with DMEM and transfected with 0.4 µg of plasmid DNA by using the 
effectene transfection reagent (Qiagen) according to the manufacturer's instruction. After 
incubation at 37°C, 5 % CO2 for 18 hrs, the cells were washed twice with PBS and 
harvested for further analysis. 
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2.4.4. Induction of Gluthionine S-transferase (GST) - fusion protein expression in 
E.coli BL21 cells 
 Three single colonies of E.coli BL21 were inoculated in 1 0ml 1X LB/ampicilin at 
37oC overnight with shaking. Ten milliliters were used to inoculate in 1 liter of 2X LB 
and incubate at 37oC. Until OD600nm reached 0.6 - 0.8, the expression of the GST - fusion 
protein was induced with 1mM IPTG for 3 hrs. Each 100ml culture was centrifuged at 
2500rpm for 20 min. Supernatant was removed and pellet was kept at -20o C. 
 
2.5. Cell manipulation 
2.5.1. Labeling mammalian cells with 35S methionine  
At four hours post-transfection, cells were washed twice with methionine-free 
DMEM and starved in methionine-free DMEM for 30 min and then labeled with 25 
mCi/ml [35S] methionine. At 18 hr post-transfection, the 35S labeled cells were washed 
twice with PBS and harvested with appropriate buffer.   
 
2.5.2. Cell treatment with proteosome inhibitors 
 At 6 hrs post-transfection, each of 6 well-plate cells was changed with 2ml fresh 
DMEM. Ten micro-liters of lactacystin and 10 μl of 4-hydroxy-5-iodo-3-nitro- 
phenylacetyl-leucyl-leucyl-leucine vinyl sulfone (NLVS) were added to make the final 
concentration to 4 μM lactacystin and 8 μM NLVS. As these two proteosome inhibitors 




2.6. Protein manipulation 
2.6.1. Treatment with PGNase F 
Total cell lysates prepared from Cos-7 cells were directly treated with 4µl 
PGNAse F (New England Biolab) for 2 hrs at 37o C. The sample was separated on 20% 
SDS-PAGE and analyzed by Western Blot with anti-Flag antibody.   
 
2.6.2. Urea dialysis 
 One hundred mili-liters of the inducted bacteria culture were pelleted. The pellet 
was washed with 100 ml ice cold PBS in the presence of protein inhibitors from Roche. 
The washed pellet was resuspended in 60 ml of PBS with PI, and sonicated on ice. The 
sonicated sample was centrifuged at 12000rpm for 15 min.  
 Each pellet was added to 30 ml solution I [8 M Urea, 50 mM NaHCO3 (pH 9), 1 
mM DTT, 1 mM EDTA] and shaked at RT for 1 hr. The mixture was centrifuged at 
maximum speed for 15 min at RT. The supernatant was transferred to a dialysis tube 
(Pierce).  
 Dialysis was carried out at RT in 500 ml of solution II [4M Urea, 50mM NaHCO3  
(pH 9), 1 mM DTT, 1 mM EDTA] for 1 hr. Subsequently, the tube was dialyzed in 500 
ml of solution III [2 M Urea, 50 mM NaHCO3 (pH 9), 1 mM DTT, 1 mM EDTA] at 4oC 
for 1 hr. This step was repeated once with fresh solution III. Next, the tube was dialyzed 
in 200 ml of solution IV [50 mM NaHCO3 (pH 8.3), 1 mM DTT, 1 mM EDTA] at 4oC 
for 1 hr. This tube then is dialysized in 500 ml of solutionV [50 mM NaHCO3 (pH 9), 1 
mM DTT, 1 mM EDTA] at 4oC for 1 hr or overnight. The dialysized mixture was 
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centrifuged at maximum speed for 30 min. Supernatant was collected and kept at 4oC for 
further analysis. 
 
2.6.3. Prebinding protein to gluthionine sepharose beads  
 50 μl of gluthionine Sepharose beads (Amersham) was washed once with PBS and 
mixed with 600 μl of dialysized supernatant or sonicated supernatant of the culture 
expressing GST or GST fusion proteins.  The complex was shook at room temperature for 
30 min. The beads were then washed three times with PBS.  The protein prebound beads 
were kept 4oC for further experiments. 
 
2.6.4. GST pull-down assay  
 Pull-down with the 35S labeled cell lysate: 500 μl of 35S methionine labeled cell 
lysate were incubated with 50 μl of GST prebound beads and incubated at 4oC for 2 hrs.  
The mixtures were then centrifuged at 13000 rpm for 2 min in order to preclear non-
specific binding proteins. The precleared supernatants were incubated with 30 μl of beads 
prebound with GST or GST-fusion proteins and incubated at 4oC for 2 hrs. The beads 
were washed with RIPA buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5 % sodium 
deoxycholate, 0.5 % Nonidet P-40, 0.05 % SDS] for three times and resolved in SDS-
PAGE.  Protein bands were visualized with autography.  
Pull-down with unlabeled cell lysate: cell lysate was directly mixed with beads 
prebound with GST or GST-fusion protein and incubated at 4oC for 2 hrs. The beads were 
washed with RIPA buffer three times and resolved in sodium dodecyl sulfate-
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polyacrylamide gel electrophoresis (SDS-PAGE).  Western blot with appropriate 
antibodies was used to analyze results. 
 
2.6.5. Immunoprecipitation 
Transfected mammalian cells were washed one time with PBS, and lysed with 500 
µl of RIPA buffer plus proteinase inhibitors (Roche). Cell debris was removed by 
centrifuge at 13000 rpm for 30 min at 4°C.  The supernatant was incubated with 1 µg of 
appropriate antibodies for 2 hrs at room temperature with shaking. The mixtures were 
incubated with 50 µl protein A conjugated agarose beads (KLP) for 2 hrs. Subsequently, 
the beads were washed three times with RIPA buffer. The washed beads were added with 
30 μl of 2 times Laemmli's sample buffer and were analyzed by Western blot.  
For the 35S labeled in vitro translation products, 10 µl of sample was lysed with 90 
µl of RIPA buffer before the addition of appropriate antibodies. 
 
2.7. Protein analysis 
2.7.1. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
 Discontinuous SDS-PAGE systems were carried out according to Laemmli’s 
methodology.  5 % stracking gel and resolving gel of various concentrations (8 %,   10 %, 
12 % and 20 %) were cast between two glass plates (BIORAD). Cell lysates or in vitro 
translation products were mixed with 2 X Laemmli's sample buffer [24 mM Tris.HCl (pH 
6.8), 100 mM DTT, 2 % SDS, 0.1 % (w/v) bromoblue phenol, 20 % (v/v)glycerol]. The 
samples were boiled at 100oC for 5 min and cooled on ice before loading on gel.  
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 Gel system was dammed in tank with the running buffer [25 mM Tris-HCL, 192 
mM glycine, 0.1 % (w/v) SDS, pH 8.3]. Gels were run vertically at constant current of 10 
mA when the samples were in stacking gel and increased to 20mA when the samples 
were in the resolving gel.  
 
2.7.2. Autography 
 SDS-PAGE gels for the 35S methionine labeled samples were fixed in destaining 
buffer [50 % (v/v) methanol and 10 %(v/v) acetic acid] for 30 min. The signals on the 
gels were enhanced in Amplify solution (Amersham) for 15 min.  Gel was dried at 80oC 
for 1 hr and cooled at room tempearture for 15 min. Subsequently, the gel was exposed to 
X-Ray Film (Biomax, Kodak) for 2 days at - 80o C. 
 
2.7.3. Wet transfer 
 SDS-PAGE gels and polyvinyldifluoride (PDVF) membrane (BIORAD) were 
presoaked in 100 % methanol for a few seconds and were subsequently soaked with cold 
wet transfer buffer [ 25 mM Tris, 190 mM glycine, 20 % (v/v) methanol]. The SDS-
PAGE gels, PDVF membrane and filter paper were assembled into the wet transfer 
cassette following the manufacture's instruction. The cassette was put into a reservoir 
filled with ice cold wet transfer buffer. The wet transfer was run at a constant voltage of 





2.7.4. Western blot analysis 
After the wet transfer, the PVDF membrane was blocked with 10 % skim milk for 
1 hr followed by 1 hour incubation with appropriate primary antibodies. The membrane 
was washed for 10 min with PBST [PBS containing 0.1% (v/v)  Tween 20] for five times. 
The membrane was continuously incubated with appropriate secondary antibodies 
conjugated with HRP for 1 hr. Subsequently, the membrane was washed five times with 
PBT for 10 min each interval.  Proteins bound to membrane were detected by using ECL 
plus Western blot detection system buffer (Amersham).  
 When necessary, the membrane can be reincubated with another primary antibody 
after the signals were stripped with stripping buffer [ 2 % (v/v) SDS, 100 mM β-
mercaptoethanol, 62.5 mM Tris-HCl, pH 6.8] for 30 min at 55oC and washed extensively 
with PBST. 
 
2.7.5. Coommassie blue staining 
   Protein separated on SDS-PAGE gels were stained with Coommassie blue [0.05 
% Coommassie blue R-250 (SIGMA), 500 ml methanol, 100 ml acetic acid, 400 ml H2O] 
for 30 min at room temperature with shaking.  The gels were then destained with 
distaining buffer [500 ml methanol, 100 ml acetic acid, 400 ml H2O] till protein bands on 
gels can be visualized clearly. 
 
2.8. Microscopy and immunofluorescence 
Mammalian cells were seeded on 4-well chamber slides (Iwaki) and grew for 
overnight. Cells were transfected with appropriate plasmid DNA cloned in pFlag (Liu 
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et.al. 1994) or pXJ40 (Xiao et.al.1991). At 18 hour normal post-transfection, the cells 
were rinsed with PBS, and fixed using 4 % (v/v) paraformaldehyde for 10 min. 
Subsequently, the cells were permeablized with 0.2 % (v/v)  Triton X-100.  After 1 hour 
incubation with appropriate primary antibodies diluted at 1:200 in PBS containing 5 % 
(v/v) goat serum and 5 % (v/v) bovine serum albumin at room temperature, the cells were 
washed three times with PBS. The cells were then incubated with flourescein 
isothiocyanate conjugated secondary antibodies diluted at 1:200 in PBS with 5% (v/v) 
goat serum and 5% (v/v) bovine serum albumin at 4°C for 1 hr and washed three times 
with PBS. Coverslips were mounted with fluorescence mounting medium reagent 
(DAKO). 
Visualization was done using Olympus IX70 Inverted Microscope (Olympus) or  
Radiance 2000 Confocal Microscope (BIORAD). Dual labeled cells were viewed for co-
localization by superimposing the fluorescent images.  The region of overlap in the 











CHAPTER 3: RESULTS 
In animal and early human isolates, the subgenomic mRNA8 of SARS-CoV was 
predicted to contain a single ORF 8 (Guan et.al., 2003).  The deletion of 29 nucleotides 
(between T27867 and A27868 for strain SG2774 (accession No: AY283798) gave rise to two 
separate ORFs (ORF 8a and 8b) in most human isolates collected at the late stages of  the 
SARS outbreak (Fig.16.).  
ORF 8a and 8b are predicted to encode two small proteins, 8a and 8b, and ORF 8 
codes for a single protein 8ab, a fusion form of the proteins 8a and 8b. ORF 8a is 
predicted to encode a 39-amino acid protein; ORF 8b encodes an 84-amino acid protein 
and ORF 8ab codes for a 122-amino acid protein. This project was concentrated on 
studying the protein expression, characteristics and functions of proteins encoded by ORF 
8a/b, ORF 8a, ORF 8b and ORF 8. 
 
3.1. Cloning and expression of SARS-CoV mRNA 8 
 Four different fragments were PCR amplified and cloned into pKT0 plasmid in 
which a Flag epitope was fused to each fragment at its 5' ends. These plasmids are known 
as pF-8a/b, pF-8a, pF-8b and pF-8ab. Another p8a/b using pKT0 as vector was 
constructed, in which fragment 8a/b was cloned with its TRS at the 5' end.  Diagram of 
the constructs were shown in Fig.3.1.  
 Constructs pF8a, pF-8b and pF-8ab were expressed using TnT transcription 
coupled translation wheat germ extracts (WG) in the presence of [35S] methionine.  Single 
protein bands of 5.3, 10.2 and 14.4 kDa, corresponding to Flag-tagged proteins 8a, 8b and 































































































































































































































































































































































































































































































































































However, in the expression of p8a/b and pF-8a/b (Fig.3.2a, lanes 1 and 2), single bands of 
sizes 4.3 and 5.3 kDa were detected, corresponding to the unflagged 8a protein only and 
Flag-tagged 8a, respectively. No protein 8b band was detected.  
Expression of the four constructs p8a/b, pF-8a/b, pF-8b and pF-8ab in rabbit 
reticulocyte lysates (RRL) in the presence of [35S] methionine showed similar results 
(Fig.3.2b, lanes 1-4).  Multiple bands with every increase of approximately 10 kDa were 
detected in the expression of pF-8b and pF-8ab (Fig.3.2b, lanes 3 and 4).  
Immunoprecipitation using rabbit anti-8b polyclonal antibodies was carried out in order to 
investigate whether these bands were related to the 8b region. As shown in Fig.3.2b, the 
10.2-kDa 8b and the 14.4-kDa 8ab together with their corresponding ladder bands were 
precipitated with anti-8b antibodies (lanes 7 and 8). Various ubiquitinated proteins were 
initially discovered in conjugation with ubiquitin by formation of the typical ladder bands 
when the proteins were translated in vitro by rabbit reticulocyte lysates (Merrick, 1983; 
Iwamuro et.al., 1999). Therefore, the patterns of these bands suggested ubiquitination of 
the proteins 8b and 8ab in the expression system.   
Expression of these constructs was then carried out in Cos-7 cells using the 
vaccinia/T7 expression system.  As shown in Fig.3.3a, the expression of Flag-tagged 8a, 
8b, and 8ab were detected in cells transfected with the corresponding constructs by 
Western blot analysis using anti-Flag antibodies (lanes 2-4). Cells were also transfected 
with p8a/b as a negative control. The absence of protein bands demonstrated the binding 





























b. Plasmids p8a/b, pF-8a/b, pF-8b and pF8ab were in 
vitro translated using rabbit reticulocyte lysates (RRL) 
in the presence of 35S methionine (lanes 1 to 4). 
Subsequently, translation products were subjected to 
immunoprecipitation (IP) using anti-8b antibodies 
(lanes 5 to 8). The expression of protein 8b was not 
observed from p8a/b and pF-8a/b (lanes 1, 2, 5 and 6). 
The slowly migrating bands were consistently 
observed in in vitro translation products (lanes 3 and 
4) and in IP results (lanes 7 and 8) using anti-8b 
antibody, indicating that protein 8b and 8ab might be 


































a. Plasmids p8a/b, pF-8a/b, pF-8a, p-F8b and pF-
8ab were in vitro translated using wheat germ 
extracts in the presence of 35S methionine. The 
proteins were separated in 20% SDS-PAGE and 
visualized by autography (lanes 1-5). Plasmid 
p8a/b expressed a 4.3 kDa protein band (lane 1) 
pF-8a/b (lane 2) and pF-8a (lane 3) expressed a 
5.3 kDa protein band. pF-8b (lane 4) and pF-8ab 
(lane 5) expressed a 10.2 kDa and  a 14.4kDa 
band, respectively. 
 






























































a. Plasmids p8a/b, pF-8a/b, p-F8b and pF-8ab were 
transfected into Cos-7 cells at 4 hour 
posttransfection with recombinant vaccinia/T7. The 
proteins were separated by 20% SDS-PAGE and 
analyzed by Western blot using anti-Flag 
antibodies. The expression of pF-8a/b was also 
obtained 5.3 kDa band (lanes 2). The expression of 
pF-8b and pF-8ab were also detected as bands of 10 
and 14.4 kDa, repectively (lanes 3 and 4). The 
protein expression of p8a/b was not detected due to 
the specific - binding of anti-Flag antibodies. The 
typical ladder-bands were detected in the expression 
of pF-8b (lanen 3) and pF-8ab (lane 4). An extra 
protein band (8ab*) was observed from expression 
of pF-8ab, indicating that this protein might have 
undergone post-translational modification. IB: 
immunoblotting. 
Figure 3.3. Expression p8a/b, pF-8a/b, p-F8b and pF-8ab in Cos-7 cells  
b. Western blot was probed with anti-8b antibodies. 
The expression of protein 8b from p8a/b and pF-
8a/b was not detected. 
An extra protein band (8ab*) was observed from the 



















































vitro translation in RRL were also detected in cells expressing pF-8b and pF-8ab (Fig. 
3.3a, lanes 3 and 4).   
 In a separate analysis using anti-8b antibodies, the 8b protein was only detected in 
cells transfected with pF-8b and pF-8ab but not in cells transfected with either p8a/b or 
pF-8a/b (Fig.3.3b). In addition to the 14.4 kDa band, a concomitant band (8ab*) was also 
observed in cells expressing pF-8ab (Fig. 3.3b, lane 4).  It may represent a post-
translationally modified 8ab protein.  
3.2. Glycosylation of the 8ab fusion protein 
Analysis of the protein sequence of 8b and 8ab using the glycomod program 
predicted a potential N-linked glycosylation site on asparagine residue 43 (N43) of protein 
8b and asparagine residue 81(N81) of fusion protein, 8ab.  
 Based on the above prediction, total cell lysates prepared from cells expressing the 
Flag-tagged 8b and 8ab proteins were treated with an endoglycosidase, PNGase F to test 
the possibility of N-linked glycosylation of these proteins.  As shown in Fig. 3.4a, the 
8ab* band was abolished after the treatment (lane 4), implying that protein 8ab* is the 
glycosylated form of protein 8ab. On the other hand, the treatment rendered no effect on 
8b migration, suggesting that the 8b protein is not modified by N-linked glycosylation 
(Fig. 3.3a, lane 3).   
pF8abM was constructed to introduce a point mutation in the ORF 8ab. The 
resultant aspartic acid substitution of the N81 residue abolished the glycosylated protein 
8ab* band (Fig. 3.5b, lanes 2 and 5) by using both anti-Flag and anti-8b antibodies in 
Western blot analysis, confirming that N81 is the site for N-linked glycosylation of 



















































































Figure 3.4.  The post-translational modification of protein 8ab 
a. Cell lysates expressing pF-8b and pF-8ab were 
treated with PNGase F, an endoglycosidase. 
Protein expression was anaylized by Western Blot 
using anti-Flag antibodies.When treated with 
PNGase F, the upper 8ab* band was disappeared 
in cell lysates expressing pF-8ab (lane 4), 
suggesting that it could be N-glycosylated  protein 
8ab. No effect was observed with the treated 
protein 8b (lane 3). 
 
b. Plasmids pF-8ab and pF-8b were expressed in Cos-
7 and HeLa cells and analyzed with Western Blot 
using anti-Flag antibodies. The expression of 
construct in Cos 7 cells yielded similar amounts of the 
modified and unmodified 8ab (lane 2), while a higher 
ratio of the glycosylated form of 8ab protein was 




























Figure 3.5. The glycosylated site of protein 8ab and the rapid degradation of 8abM in 
Cos-7 cells.  
Three plasmids pF-8b, pF-8abM and pF-8ab were transfected into Cos-7 and analyzed by 
Western blot with anti-Flag antibody or with anti-8b antibodies.    
a. Schematic representation of the cleaved fragments of protein 8b and 8ab*. 
b. Disappearance of the upper 8ab* band in expression of pF-8abM in Cos-7 indicated that 
N81 is the site for N-linked glycosylation of protein 8ab (lanes 2 and 5). In addition to the 
disappearance of 8ab* band, multiple rapidly migrating bands were observed (lanes 2 and 5). 
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Western blot analysis of cells expressing pF8abM using anti-Flag antibody 
detected two rapidly migrating bands of approximately 10 kDa and 5 kDa (Fig. 3.5b, lane 
2). Since Flag sequence was tagged at the N-terminal of protein 8abM, these detected 
fragments predictably correlate to the N-terminal region of the 8ab (Fig. 3.5a, upper 
diagram). In addition, analysis using polyclonal anti-8b antibodies which could bind to 
fragment 8b of protein 8abM detected two other bands of approximately 7 and 3 kDa (Fig. 
3.5b, lane 5), correlating to the C-terminal region of the 8abM (Fig. 3.4b, upper diagram). 
Similar rapidly migrating bands were observed with 8b protein as compared to 8ab* 
protein bands (Fig.3.5b. lanes 1 and 4). 
During the course of this study, it was also noted that F-8ab expression in different 
cell lines resulted in the detection of variable amounts of the N-linked glycosylated 8ab*.  
While the expression of construct in Cos 7 cells yielded similar amounts of the modified 
and unmodified 8ab, a higher ratio of the glycosylated form of the 8ab protein was 
detected in Hela cells (Fig. 3.4b).  
 
3.3. Ubiquitination of the 8b and 8ab proteins 
 Rabbit reticulocyte lysates are reported to contain a variety of enzymes and 
substrates to support various modifications, such as ubiquitination, of translated proteins 
(Starr et.al., 1990; Sanford et.al., 1991; Tibbles et.al., 1995). The detection of typical 
ladder bands of the 8b and 8ab proteins when the proteins were expressed in rabbit 
reticulocyte lysates indicates that they may be ubiquitinated (Fig. 3.2b lanes 3 and 4). 
Hence, the possibility of ubiquitination of proteins 8b and 8ab was further studied in intact 












Figure 3.6.  Analysis of the ubiquitination of protein 8b, 8ab and 8abM 
Plasmids pF-8b, pF-8ab, and pF-8abM were expressed in Cos-7 in the presence or absence of 
lactacystin (LC) and NLVS. Since DMSO may affect the protein translation, cells was 
separated into untreatment, DMSO treated and LC and NLVS treated samples. Protein 
expression was analyzed by Western blot using anti-Flag antibody. The accumulation of larger 
protein bands but not the full-length 8ab was observed in cells treated with LC and NLVS, 
indicating that this protein was conjugated with ubiquitin (lanes 4 to 6). This effect was not 
observed with the larger forms of protein 8b and 8abM.
1    2     3    4    5     6    7     8   9
DMSO  - +  +  - +  +  - +  +  















 Proteasome inhibitor lactacystin (4 μM) and NLVS (8 μM) dissolved in DMSO 
was added to the culture medium 6 hours post-transfection to prevent degradation of the 
ubiquinated products. As DMSO may affect the translation process, DMSO was 
separately added as a control. In the presence of DMSO alone, less transfected proteins 
were expressed (Fig. 3.6, lanes 5 and 6).  Addition of lactacystin and NLVS resulted in 
the specific accumulation of the larger bands in cells over-expressing F8ab, but has no 
effect on the full length and the glycosylated form (Fig. 3.6, lane 6). This indicated that 
these bands represented the ubiquitin-conjugated forms of F8-ab. However, this effect was 
not observed in cells expressing F-8b and F8-abM (Fig. 3.6, lanes 3 and 9). 
 
3.4. Binding of 8b and 8ab proteins to mono- and polyubiquitin 
 To confirm that the 8a and 8ab proteins are posttranslationally modified by 
ubiquitination, co-expression of these proteins with a Myc-tagged ubiquitin in Cos-7 cells 
were carried out, and the expression and interaction of the proteins were determined by 
Western blot and coimmunoprecipitation assays.  As shown in Fig. 3.7a, the expression of 
mono- and poly-ubiquitin was detected in cells transfected with Myc-tagged ubiquitin 
plasmid.  On the other hand, despite the presence of weak poly-ubiquitin bands, the mono-
ubiquitin band was not detected in cells co-expressing the Myc-tagged ubiquitin with 
either 8b (Fig. 3.7a, lane 1) or 8ab (Fig. 3.7a, lane 2).  
 Immunoprecipitation of cell lysates prepared from these transfected cells with 
anti-Flag antibody, followed by Western blot analysis with anti-Myc antibody, led to the 
detection of strong poly-ubiquitin bands in cells co-expressing the Myc-tagged ubiquitin 
and the Flag-tagged 8ab (Fig. 3.7a, lane 5).  Western blot analysis using anti-Flag 
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antibody of the same membrane showed the detection of massive free and ubiquitin-
conjugated 8ab, demonstrating the efficiency of the immunoprecipitation (Fig. 3.7a, lane 
8). However, it was observed that much less protein 8b was immunoprecipitated by the 
anti-Flag antibody in the same blot, possibly due to a lower transfection efficiency of 
protein 8b (Fig3.7a, lane 7). This explained the detection of much weaker poly-ubiquitin 
bands in cells co-expressing the Myc-tagged ubiquitin and the Flag-tagged 8b (Fig. 3.7a, 
lane 4).  
 Similarly, Western blot analysis using anti-Flag antibody detected Flag-tagged 8b 
(Fig. 3.7b, lane 2) and 8ab (Fig. 3.7b, lanes 3 and 4) either expressed alone or co-
expressed with the Myc-tagged ubiquitin.  The same cell lysates were immunoprecipitated 
with anti-Myc antibody and subsequently analyzed by Western blot with anti-Flag 
antibody.  In addition to the detection of slowly migrating bands of protein 8ab (Fig.3.7b, 
lane 7), the Flag-tagged 8b (Fig. 3.7b, lane 6) and 8ab (Fig 3.7b, lane 7) were efficiently 
detected when they were co-expressed with the Myc-tagged ubiquitin.  No detection of 
the 8ab protein was observed when it was expressed on its own (Fig. 3.7b, lane 8).  
Western blot analysis using anti-Myc antibody of the same membrane showed the 
detection of mono- and poly-ubiquitin in cells expressing just the Myc-tagged ubiquitin 
protein (Fig. 3.7b, lane 9).  The mono-ubiquitin band was marginally detected when it was 
co-expressed with 8b (Fig. 3.7b, lane 10), but was not detected when co-expressed with 
8ab (Fig. 3.7b, lane 11).  
 To rule out the effect of cellular deubiquitin hydrolases activity, the 
immunoprecipitational experiments were repeated in the presence of deubiquitin inhibitor. 

























a. Plasmids pF-8b or pF-8ab and pMyc-Ub 
were co-expressed in Cos-7 cells in the 
presence of recombinant vaccinia/T7. 
Immunoprecipitation of cell lysates was done 
using anti-Flag antibody, followed by 
Western blot analysis using anti-Myc and 
anti-Flag antibodies. Lanes 1 to 3 show the 
ubiquitin expression in co-transfected cells. 
Low expression of ubiquitin was observed in 
co-transfection (lanes 1 and 2). Proteins 8b 
and 8ab were immunoprecipitated together 
with ubiquitin in co-transfected cell lysates 
but not in single transfection (Lanes 4 to 6). 
The efficiency of immunoprecipitation of 
protein 8b and 8ab by anti-Flag antibodies 
shown in lanes 7 to 9. Much less protein 8b 
was precipitated down by anti-Flag antibodies 
(lane 4), possibly due to a lower transfection 












Myc-Ub +  +  +  +  +  +  +  +  +  
Flag-8ab  - +  - - +  - - +  -





1     2     3    4    5     6     7    8     9     
IP: α-Myc
IB: α-Flag
Myc-Ub +  +  +  - +  +  +  - +  +  +  -
Flag-8ab  - - +  +  - - +  +  - - +  + 














1    2    3    4    5     6    7    8        9   10  11   12  
Figure  3.7. Immunoprecipitaion and Western blot analysis of the binding  of protein 8b 
and 8ab to ubiquitin.  
b. The co-transfected cell lysates were immunoprecipitated using anti-Myc antibodies. Lanes 1to 
4 show the protein expression of pF-8b and pF-8ab by Western blot analysis using anti-Flag 
antibodies. Proteins 8b and 8ab were efficiently co-immunoprecipitated by anti-Myc antibodies 
in the presence of ubiquitin (lanes 6 and 7). Lanes 9 to 12 show the efficiency of 































Myc-Ubi +  +  +  - +  +  +  -
Flag-8ab  - - +  +  - - +  + 










1    2     3   4    5    6     7    8
Figure 3.8. Immunoprecipitation with anti-Flag antibody and anti-Myc antibody in the 
presence of deubiquitin inhibitors 
a. Immunoprecipitation of ubiquitin and 
protein 8b or protein 8ab using -anti-Flag 
antibodies in the presence of de-ubiquitin 
inhibitors.Lanes 1 to 4 show the ubiquitin 
expression in co-transfected cells. Ubiquitin 
was co-immunoprecipitated with proteins 8b 
and 8ab in co-transfected cell lysates (lanes 
6 and 7) but not in the single transfection 
(Lanes 5 and 8).  
b. Immunoprecipitation of ubiquitin and 
protein 8b or protein 8ab using anti-Myc 
antibodies in the presence of deubiquitin 
inhibitors.  
Lanes 1to 4 show the protein expression of 
pF-8b and pF-8ab by using Western blot with 
anti-Flag antibodies. Proteins 8b and 8ab were 
co-immunoprecipitated with anti-Myc 
antibodies in the presence of ubiquitin and 
analyzed by Western blot using anti-Flag 
antibodies   (lanes 6 and 7), indicated that 





Myc-Ubi - +  +  +  - +  +  + 
Flag-8ab  - - +  +  - - +  + 







































a. Plasmids pGEX-5X-1(GST), pGEX-5X-
1/8b (GST-8b) and pGEX-5X-1/8ab (GST-
8ab) were expressed in E.coli BL21 and 
proteins were prebound to GST beads.  
Equal amounts of GST (lane 1), GST-8b 
(lane 2) and GST-8ab (lane 3) prebound 
beads used in pull-down assay were checked 









































































































Figure  3.9. Pull down assay of mono- and poly-ubiquitin by GST-8b and GST-8ab proteins 
b. Pull-down assay of ubiquitin expressed in 
cell with or without 35S methionine labelling.  
Cell lysates expressing ubiquitin with or 
without 35S methionie were mixed with 
protein prebound beads. The beads were 
separated by 20% SDS-PAGE. The results 
were analyzed either by autography for  the 
35S methionie labeled cell lysates or by 
Western blot using anti-Myc antibodies for 
unlabeled cell lysates. Mono-ubiquitin and 
poly-ubiquitin were consistently pull-down 
with GST-8b and GST-8ab but not with GST 






demonstrated that proteins 8b and 8ab could interact with mono- and poly-ubiquitin. To 
further confirm these results, the 8ab and 8b proteins were expressed in E. coli as GST 
fusion proteins and purified.  As shown in Fig. 3.9a, relatively pure GST, GST-8b and 
GST-8ab proteins were obtained (lanes 1 to 3).  Equal amounts of GST, GST-8b and 
GST-8ab proteins were pre-bound to GST beads prior to a pull-down assay. GST pre-
cleared [35S] methionine/cysteine-labeled lysates prepared from cells overexpressing the 
Myc-tagged ubiquitin were then added to the various pre-bound GST beads and incubated 
for 2 hours.  As shown in Fig. 3.9b, efficient pull-down of mono- and poly-ubiquitin by 
GST-8b and GST-8ab proteins was observed (lanes 3 and 4).  However, no mono- and 
poly-ubiquitin bands were detected when only GST protein was used (Fig. 3.9b, lane 1).  
These results confirmed that 8b and 8ab protein can non-covalently bind to the mono- and 
poly-ubiquitin molecules.  
 Pull-down experiments were repeated and then analysed by Western blot using 
anti-Myc antibody. As shown in Fig.3.9b, various forms of poly-ubiquitin were pull-down 
with GST-8b and GST-8ab but not with GST alone, showing consistent results (lanes 6, 7 
and 8). However, a faint band of mono-ubiquitin was observed due to weak binding of 
ubiquitin to protein 8b and 8ab. 
 
3.5. Binding of 8b and 8ab proteins to ubiquitinated p53 and IκBα. 
 We next sought to test if the 8b and 8ab proteins can bind to ubiquitinated host 
proteins.  Two proteins, p53 and IκBα, were tested.   
First, p53, the Myc-tagged ubiquitin and the Flag-tagged 8b or 8ab were co-
































Myc-Ub +  +  +  +  +    +  +  +  +  + 
Flag-8ab  - - +  - +    - - +  - + 
Flag-8b  - +  - +  - - +  - +  -




1     2     3     4     5       6     7     8    9   10   
a 
Figure 3.10. Binding of protein 8b and protein 8ab to ubiquitinated p53 
p53, the Myc-tagged ubiquitin and the Flag-tagged 8b or 8ab were triple-transfected in H1299 
cells.  
a. Immunoprecipitation of triple-transfected cell lysates were done with anti-p53 antibodies.  
Lanes 1 to 5 show western blot results analyzing the expression of protein 8b and 8ab by anti-
Flag antibodies. Protein 8b and protein 8ab were found to co-immunoprecipitate with anti-p53 
antibodies in the presence of both p53 protein and ubiquitin but not in the presence of ubiquitin 
alone (Lane 7 and 8). 
b. The expression of ubiquitin-conjugated full-length p53 and full-length p53 in triple-
transfected cell lysates were analyzed by Western blot using anti-p53 antibodies (Lanes 1 to 3). 
The immunoprecipitation with the cell lysates were carried out with anti-Flag antibodies and the 
results were analyzed by Western blot using anti-p53 antibodies. The ubiquitin-conjugated full-
length p53 and the degraded intermediate form of p53 were co-immunoprecipitated with protein 
8b and protein 8ab in the presence of ubiquitin (lanes 7 and 8), indicating the binding of protein 
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Figure 3.11. Binding of proteins 8b and 8ab to ubiquitinated IκBα  
IκBα, the Myc-tagged ubiquitin and the Flag-tagged 8b or 8ab were triple-transfected into 
Cos-7 cells. The expression of ubiquitin-conjugated IκBα in triple-transfected cell lysates 
was analyzed by Western blot using anti- IκBα antibodies (Lanes 1 to 3). 
Immunoprecipitation was done with anti-Flag antibodies and protein expression was 
analyzed by Western blot using anti- IκBα antibodies. The ubiquitin-conjugated IκBα 
were also co-immunoprecipitated with proteins 8b and 8ab (lanes 7 and 10).  
Myc-Ub +   +   +   +   +   +   +   +   +   +  
Flag-8ab  - +   - +   - - +   - +   -
Flag-8b  - - +   - +   - - +   - +
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either with anti-p53 or anti-Flag antibody.  As shown in Fig. 3.10a, the 8a and 8ab 
proteins were efficiently precipitated by an anti-p53 antibody when they were co-
expressed in cells with p53 and the Myc–tagged ubiquitin (lanes 7 and 8).  The 8b and 8ab 
protein were not detected in the same co-immunoprecipitation experiments when the two 
proteins were co-expressed with the Myc–tagged ubiquitin (lanes 9 and 10). 
Immunoprecipitation of the cell lysates with anti-Flag antibody led to the detection of the 
ubiquitin-conjugated full-length p53 (Ub-p53) and its putative degraded intermediate 
forms (Ub-53*) by Western blot with anti-p53 antibody (Fig. 3.10b, lanes 7 and 8).  In the 
same assay, the non-conjugated p53 was also detected (Fig. 3.10b, lanes 7 and 8).  
 Similarly, co-expression of 8b or 8ab proteins with IκBα and the Myc-tagged 
ubiquitin led to the detection of the ubiquitinated IκBα (Fig. 3.11, lanes 7 and 10) in the 
co-immunoprecipitation experiments when anti-Flag antibody and anti-IκBα were used 
for immunoprecipitation and Western blot, respectively. 
 
3.6. Binding of the 8b and 8ab proteins to Interferon regulatory factor 3 (IRF 3) 
SARS-CoV was found to be an inefficient IFN-β inducer because it was reported 
to affect IRF3, an upsteam stimulator of IFN-β gene (Cheung et.al., 2005). Upon the virus 
infection, IRF3 can be translocated to the nucleus, and be phosphorylated, homodimerized 
before binding to its coactivator protein CREB-binding protein (CBP) to stimulate the 
transcription of IFN-β gene (Hiscott et.al., 1999; Garcia et.al., 2001; Suhara et.al., 2002). 
Spiegel M. et.al (2005) observed that upon infection with SARS-CoV, IRF3 was found to 
be sequestered in the cytoplasm and it was neither phosphorylated nor homodimerized, 
and failed to bind to its coactivator protein CBP. Currently no SARS-CoV proteins have 
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been reported to bind to IRF3. We therefore tested whether the 8a, 8b and 8ab proteins 
can bind to IRF3. Co-expression of these proteins with IRF3 was carried out in Cos-7 
cells. The expression and interaction of these proteins were determined by Western blot 
and coimmunoprecipitation.  
 Expression of proteins IRF 3, 8a, 8b and 8ab in cells were shown in Fig.3.12. IRF3 
was expressed as a 50 kDa band (Fig.3.12a, lanes 1 to 4). Immunoprecipitation of cell 
lysates prepared from these transfected cells were performed in the presence of anti-IRF3 
antibody, followed by Western blotting with anti-Flag antibody. A strong band of the 8b 
protein (Fig.3.12b, lane 8) and weak bands of protein 8ab and its glycosylated 8ab protein 
form were detected (Fig.3.12b, lane9), indicative of a plausible binding between these 
SARS-CoV proteins with IRF3. No 8a protein band could be observed (Fig.3.12b, lane 6).  
 Immunoprecipitation using anti-Flag antibody and Western blotting using anti-
IRF3 were carried out. The interaction was again observed when the IRF 3 were 
coimmunoprecipiated in samples where it was co-expressed with either proteins 8b or 
8ab, but not with protein 8a (Fig.3.12a, lanes 7, 8 and 9). The coimmunprecipitation of 
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Flag-8ab - - - + +   - - - + +
Flag-8b - - + - - - - + - -
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Figure  3.12. Binding of proteins 8b and 8ab to IRF 3 
a. Plasmids pF8a, pF8b and pF8ab were 
coexpressed with IRF 3 in Cos-7 cells. Cell 
lysates were immunoprecipitated with anti-
Flag antibodies and detected with Western 
blot using anti-IRF3 antibody. The 
expression of IRF 3 in the cell lysates were 
analyzed by western blot using anti-IRF 3 
antibodies (lanes 1 to 5). IRF 3 was 
immunoprecipitated with proteins 8b (lane 
8) and 8ab (lane 9) but not with protein 8a 
(lane 2) in the co-expression. Single 
expression of protein 8ab was used as the 
control for the immunoprecipitation (lane 
10). Increasing amount of IRF 3 was 
precipitated with protein 8b as compared to 
protein 8ab. 
b. The co-transfected cell lysates were 
immunoprecipitated with anti-Flag antibodies 
and detected with Wester blot using anti-
IRF3 antibody. 
The expression of protein 8a, 8b and 8ab 
were analyzed by western blot using anti-
Flag antibodies (lanes 1 to 5).  
Consistenly, proteins 8b and 8ab but not 
protein 8a was immunoprecipitated by anti-
IRF 3 antibodies (lanes 8 and 9). 
a 
8ab*
IRF3 + + + + - + + + + -
Flag-8ab - - - + + - - - + +
Flag-8b - - + - - - - + - -
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3.7. Subcellular localization of 8a, 8b and 8ab proteins 
The Flag-tagged 8a, Flag-tagged 8b and Flag-tagged 8ab cDNA fragments were 
cloned into pXJ 40 vector in order to express these proteins in Hela cells independently 
from the recombinant vaccine/T7. 
Subcellular localization of the Flag-tagged 8a, 8b and 8ab in HeLa cells were 
studied by indirect immunofluorescence with anti-Flag antibody and specific markers for 
various cellular compartments. The nucleus was stained with DAPI, which binds 
specifically to chromosome DNA (Fig 3.13, panels B, D and H); the Golgi apparatus was 
stained with p230 (Golgi marker) (Fig.3.14a, panels B, D and H); and the ER was stained 
with antibody against calnexin - an ER resident protein (Fig.3.14b, panels B, D and H). 
The results showed that the 8a, 8b and 8ab proteins did not co-localise with the nucleus 
and was thus found predominantly in the cytoplasm (Fig. 3.13). Co-staining with the 
Golgi markers was also not detected for any of the three proteins (Fig.3.14a). 
Immunofluorescent staining of cells expressing the Flag-tagged 8b protein showed that 
the protein is localized to the perinuclear region with the ER punctated staining pattern 
(Fig. 3.14b, panels D, E and F). The immunofluorescence signal for 8a and 8ab protein, 
on the other hand, only partially overlapped with the ER marker (Fig. 3.14b, panels A-C 
and G-H). Hence the precise localization of the two proteins in the transfected cells is yet 
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Figure 3. 13. Cytoplasmic localization of proteins 8a, 8b and 8ab 
pXJ/F-8a, pXJ/F-8b and pXJ/F-8ab were transfected into HeLa cells. Indirect 
immunofluorescent staining was carried out at 24 h post-transfection with mouse anti-
Flag and followed with anti-mouse secondary antibodies conjugated with flourescein 
isothiocyanate (panels A, D and G). Nucleus was visualized by staining with DAPI 
(Panels B, E and H). Panels C, F and I represents the merged images. All images were 
























































a. Indirect immunofluorescent 
staining was done using mouse 
anti-Flag and rabbit anti-p230 
antibodies. Theses proteins were 
detected by anti-mouse and anti-
rabbit secondary antibodies 
conjugated with flourescein 
isothiocyanate. Panels A, D and 
G represented the localization of 
protein 8a, 8b and 8ab in HeLa 
cells. Golgi apparatus was 
visualized in panels B, E and H. 
Panels C, F and I represent the 
merged images. All images were 
taken using Radiance 2000 
confocal microscope (BIORAD) 
with magnification 600x. None 
of the proteins were co-localized 
with Golgi. 
 
b. The dual staining of HeLa 
cells was done similarly with 
ant-Flag antibodies and anti-
calnexin, an ER marker. Protein 
8b but not protein 8a or protein 











CHAPTER 4: DISCUSSION 
4.1. Expression of protein 8a, 8b and 8ab from subgenomic mRNA 8 of SARS-CoV  
 In this study, ORF 8a was expressed in either wheat germ extracts or rabbit 
reticulocyte lysates. The expression of the protein was also observed in Cos-7 cells. 
Similarly, the translation of ORF 8ab was observed in all the translation systems used in 
this study.  In contrast, ORF 8b was only expressed when the ORF was cloned singly, 
independent of ORF 8a/b.   
 ORF 8a was expressed as a 5.3 kDa Flag-tagged protein from pF-8a and pF-8a/b 
(Fig. 3.3a and b). In either wheat germ extracts or rabbit reticulocyte lysates, the 
expression of p8a/b gave rise to a 4.3 kDa protein band, equivalent to the predicted size 
of protein 8a. However, due to the lack of a specific antibody, protein 8a from p8a/b 
could not detected in cells using non-radioactive methods.  
In SARS-CoV genomic RNA, putative ORF 8a sits immediately downstream of a 
strong body TRS (AGUCUAAACGAAAUG)( Snijder et.al., 2003). TRSs are known as 
regulatory sequences for the transcription of negative strand RNAs, which serve as 
templates for subgenomic mRNA synthesis. In fact, the subgenomic mRNA 8 was 
documented to be synthesized in SARS-CoV infected cells (Thiel et.al., 2003). The leader 
sequence and the 5' cap of genomic and subgenomic mRNA could recruit the translation 
initiation complex including the 40S ribosomal subunit (Tahara et.al., 1994). The 
ribosome then scans the mRNA and starts translation at the first AUG encountered. 
Therefore, the 5' most ORF of the genomic and subgenomic mRNA are highly translated. 
This translation mechanism is known as a cap-dependent mechanism, the so-called 
ribosomal scanning mechanism (Kozak, 1989). Recently, with the detection of protein 3a 
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and 7a from the translation of subgenomic mRNA 3 and mRNA 7, respectively, the 
majority of the 5' most ORF of genomic and subgenomic mRNAs of SARS-CoV are 
known to express proteins (Yu et.al., 2004, Qui et.al., 2005). In fact, ORF 8a is the 5' 
most ORF of subgenomic mRNA 8. Hence, ORF 8a is potentially translated by this 
scanning mechanism. Antibodies against the 8a peptide was present in patients infected 
with SARS-CoV strains carrying the 29 nucleotide deletion, implying the expression of 
the protein (Guo et.al., 2004; Tan et.al., 2005). 
ORF 8ab was expressed from pF-8ab as a 14.4 kDa Flag-tagged protein. Although 
expression of ORF 8ab from the subgenomic mRNA 8 and the production of antibodies 
against protein 8ab in patients have not established, protein 8ab was highly likely present. 
It is because ORF 8ab is the fusion form of ORF 8a and ORF 8b in the subgenomic 
mRNA 8. Hence, the translation mechanism of ORF 8ab from this subgenomic mRNA 8 
must be similar to the translation mechanism of ORF 8a.   
By the expression of pF-8b, protein 8b was detected as a 10.2 kDa Flag-tagged 
protein.  However, protein 8b was not translated from the overlapping ORF 8a/b of the 
constructs p8a/b or pF-8a/b. It was assumed that no detection of the protein was due to the 
low expression level of ORF 8b as compared with ORF 8a. In order to enrich the ORF 8b 
product, immunoprecipitation of the in vitro translation products labeled with 35S 
methionine was carried out with anti-8b antibody. However, the protein was still not 
detected. This ORF was previously speculated to be translated silently for Franfurt-1 and 
HKU isolates (Snijder et.al., 2003) and no antibodies against 8b peptides are found in 
SARS-CoV infected patients (Guo et.al., 2004).  
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Although ORF 8b was located downstream of a weak TRS in the subgenomic 
mRNA 8a/b (CUAAUAAACUCAUG) (Marra et.al., 2003), no additional subgenomic 
mRNA 8b was produced. Thus, if protein 8b is synthesized from ORF8a/b, it would be 
unlikely translated by the conventional ribosomal scanning mechanism.  
There is increasing evidence showing that some coronaviruse proteins are 
generated by other mechanisms such as leaky scanning or internal ribosome entry. Other 
coronaviruses uses these mechanisms to translate multi-products from their subgenomic 
mRNA. 
 In the leaky scanning mechanism, ribosomes will skip the first AUG and initiate 
translation at a downstream AUG (Kozak, 1989; Gray and Wrickens, 1998). It has been 
reported that leaky scanning may operate even when the second initiation site residues as 
far as 250 nucleotide downsteam of the first (Kozak, 1998). The first AUG of protein 8b 
is 85 nucleotide residues downsteam of first AUG of protein 8a (Guan et.al., 2003). Thus, 
protein 8b may translated by leaky scanning.  
Also, in internal ribosomal entry mechanism, an RNA fragment at the upstream 
region of an ORF could form a special RNA structure able to bind ribosomes, resulting in 
the initiation of translation at a downstream AUG (Gray and Wrickens, 1998; Zuniga 
et.al., 2004). For example, translation of ORF 3c of the tricistronic subgenomic mRNA 3 
of IBV is supported by an internal ribosomal entry site at the upstream RNA fragment of 
the ORF (Liu et.al., 1992). In the present study, pF-8a/b construct was cloned only with 
the coding region ORF8a/b; even in p8a/8b construct, the cloned region was extended to 
the upstream TRS of ORF8a/b. The lack of these important regions in the expression 
constructs might be a reason for the inability to detect protein 8b from ORF 8a/b.  
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4.2. Sublocalization of proteins 8a, 8b and 8ab in cells by indirect 
immunofluorescence 
 Proteins 8a, 8b and 8ab were not found in nuclei; they are the cytoplasmic 
proteins. Proteins 8a and 8ab do not reside in the ER or Golgi apparatus. In contrast, 
protein 8b is an ER protein since its staining image merged with the image of calnexin. 
The localization of proteins 8a, 8b and 8ab in the cytoplasm supports the hypothesis that 
these proteins might be involved in the pathogenesis of SARS-CoV. 
 
4.3. Glycosylation of protein 8ab 
As predicted by Glycomod Tool Program, protein 8ab potentially binds to glycan 
at residue N81. A prominent slowly migrating band (8ab*) was detected in cells. This 
band was designated as N-glycosylated form of the protein by PGNase F treatment and 
site-directed mutagenesis.  
Although predicted with a potential glycosylated sequence motif, the glycosylated 
form of protein 8b was not detected in Western blot analysis and the protein was not 
affected by the treatment of PGNase F. In addition, protein 8b was easily degraded. A 
defective glycosylated protein 8abM was rapidly degraded in cells. The protein was 
observed with multiple species of intermediate products in the Western blot analysis. 
Although the two exact cleavage sites on protein 8abM were not defined, they could be 
narrowed down - one site is on the 8a region and another on the 8b region.  
Protein 8ab was not susceptible to cleavage in cells due to its glycosylation. 
Glycosylation plays a fundamental role in oligomerization, sorting transport and 
especially in protein folding (Helenius and Aebi, 2001). During glycosylation, glycan 
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residues are transferred to Asn of the target sequence motif Asn-X- Ser/Thr on a nascent 
peptidebyoligosaccharyltransferase in eukaryotic cells (Bause, 1983). Then glycan is the 
"admission ticket" of the protein to go through protein folding or oligomerization, sorting 
and transport (Helenius and Aebi, 2001).  
Change of Asn to Asp of protein 8abM made the protein degraded more easily. In 
addition, in the absence of 8a region, protein 8b was also easily cleaved although it 
contains the potential target sequence motif of glycosylation. It is therefore speculated that 
glycosylation assists the folding of protein 8ab.  
The folding process happens in the ER and Golgi apparatus (Ou et.al., 1993; 
Hammond et.al., 1994). Protein 8ab was not localized in the Golgi apparatus. Hence, 
protein 8ab might be folded in the ER. Interestingly, calnexin-calreticulin is the cycle 
involving in the folding process of glycosylated proteins in the ER (Berdard et.al., 1997). 
In the IF study, protein 8b was co-localized with calnexin and protein 8ab was partially 
co-localized. This indirect evidence indicates that protein 8b and 8ab might bind to 
calnexin to get into the folding systems. In the folding process, calnexin and calreticulin 
bind transiently to glycosylated proteins, and subsequently the calnexin and the 
calreticulin form a complex with co-chaperon ERp57 (Silvennoinen et.al., 2004). The 
three-protein complex folds glycosylated proteins by forming correct disulfide bonds 
(Huppa and Ploegh, 1998). Protein 8ab is rich in cysteine residues at the 8a region. It is 
likely that protein 8ab acquires its proper conformation from the formation of disulfide 
bonds in 8a region. In contrast, the folding of protein 8b might be incorrect as it is not 
able to form disulfide bonds. A properly folded protein 8ab has its cleavage recognition 
sites masked and therefore it is protected from digestion. Change of Asn to Asp of the 
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Asn-Val-Thr motif of protein 8abM made the protein lose the glycosylation site. Thus, 
protein 8abM could not get into the folding systems. Cleavage sites of 8abM protein were 
exposed and the protein is easily digested.  
Glycosylated coronavirus proteins utilize the cellular sorting pathway to complete 
virion assembly and budding process. S and M proteins of SARS-CoV were highly 
glycosylated and are sorted to the assembly site by the sorting mechanism in the Golgi 
apparatus (Huang et.al., 2004; Hofmamnn and Pohlmann, 2004; Nal et.al., 2005). N-
glycans of S glycosylated protein of SARS-CoV  play a role in binding to lectin receptor 
DC (Yang et.al., 2004) or shielding neutralizing epitopes from antibody recognition (Wei 
et.al., 2004, Chen et.al., 2005 ). Using this glycosylation approach to enable proper 
folding and avoid cleavage could be another means for SARS-CoV in order to protect 
their proteins.  
When pF-8ab was expressed in different cell lines, the amounts of the glycosylated 
form of 8ab protein were varied. In Cos-7 cells, the amount of unglycosylated protein 8ab 
was found to be approximately equivalent to the amount of glycosylated 8ab protein, 
while in HeLa cells, more glycosylated protein was found as compared to unglycosylated 
protein 8ab. Therefore, human cells seem to support the glycosylation of protein 8ab.  
 
4.4. Ubiquitination of proteins 8b and 8ab 
In this study, proteins 8b and 8ab were found to bind non-covalently and 
covalently to mono and poly-ubiquitin. The ubiquitin interaction was found to facilitate 
the binding of proteins 8b and 8ab with cellular ubiquitinated proteins, suggesting that 
proteins 8b and 8ab are involved in the pathogenesis of SARS-CoV. 
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Proteins 8b and 8ab were initially shown to bind to poly-ubiquitin when the 
proteins were translated using rabbit reticulocyte lysates. Typical ladder bands of proteins 
8b and 8ab were detected. These typical ladder bands were consistently observed in 
immunoprecipitation using anti-8b antibodies, indicating the ubiquitin conjugation of 
these proteins. Rabbit reticulocyte lysates is reported to contain varieties of enzymes and 
substrates to support various modifications of translated proteins including ubiquitination 
(Starr et.al., 1990; Sanford et.al., 1991; Tibbles et.al., 1995). In addition, various 
ubiquitinated proteins were initially discovered in conjugation with ubiquitin by formation 
of typical ladder bands when the proteins were translated in vitro by rabbit reticulocyte 
lysates (Merrick, 1983; Iwamuro et.al., 1999).  
These ladder bands were also observed in the cell. In the presence of proteosome 
inhibitors, more ladder bands of protein 8ab were accumulated, confirming the ubiquitin 
conjugation of protein 8ab. The accumulation was not observed with high bands of 
protein 8b and protein 8abM.  
In addition to covalent conjugation with proteins 8b and 8ab, ubiquitin was found 
to bind non-covalently to these two proteins by co-immunoprecipitation experiments. The 
non-covalent binding of ubiquitin to proteins 8b and 8ab were further demonstrated by 
GST- pull down assays.  
As they were capable of binding non-covalently and covalently to ubiquitin, 
proteins 8b and 8ab may contain ubiquitin-binding domains (UBDs). Nine ubiquitin 
binding domains such as UIM (ubiquitin binding motif), UBA (ubiquitin associated 
domains) etc. are identified (Hofmann and Falquet, 2001; Shiba et.al., 2004; Slagsvold 
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et.al, 2005) . Most of UBDs are able to bind to ubiquitin non-covalently and covalently 
(Hicke et.al., 2005).  
Many UBDs were initially discovered by homology search with the identified 
ubiquitin binding domains (Donaldson, 2003; Hofmann and Falquet, 2003; Hicke et.al., 
2005). However, proteins 8b and 8ab do not have any homology with any known UBD, 
suggesting that they might contain a novel UBDs. Proteins 8b and 8ab but not protein 8a 
was conjugated with poly-ubiquitin and form complex with mono and poly-ubiquitin. 
Thus, the novel ubiquitin binding domain of proteins 8b and 8ab is likely located in the 8b 
region. 
 The ubiquitin conjugation of UBDs is suggested to assist the formation of a 
complex between the domain and free mono-poly-ubiquitin. Interestingly, UBDs are able 
to bind to other ubiquinated proteins (Hicke et.al., 2005), disturbing the function or 
transportation of polyubiquitinated proteins (Shiba et.al., 2004; Slagsvold et.al., 2005). By 
immunoprecipitation, proteins 8b and 8ab were established to bind to the ubiquitinated 
form of p53 and IκBα.  
For p53, its ubiquination and degradation by proteosomes play an important role in 
maintaining a constant level of the protein in cells (Maki et.al., 1996; Prives and Hall, 
1999). Binding of 8b and 8ab proteins to polyubiquitinated p53 affects the turnover of the 
p53 protein in the cell and therefore affects other pathways downstream of p53. Many 
viral proteins are reported to be involved in inactivation of p53 (Lane and Crawford, 
1979; Kao et.al., 1990; Szekely et.al., 1993). For example, E6 oncoprotein of human 
papillomavirus is reported to inactivate p53 protein by promoting the ubiquitination of 
p53 protein (Scheffner et.al., 1990). 
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Various forms of polyubiquitinated IκBα were also detected in co-
immunoprecipitation experiments, indicating that proteins 8b and 8ab could possibly bind 
to the polyubiquitinated forms of IκBα.  The ubiquitination and degradation of the IkBα 
free the cytoplamic nuclear factor kappa β (NFκβ) which then translocated to the nucleus 
where it can activate transcription of cytokine and chemokine genes. The impairment of 
the ubiquitination of IkBα affects the activation of NFκβ, leading to the inhibition of the 
immune systems (Baldwin, 1996).  
As p53 and IκBα  were chosen randomly, it is suggested the wide effect of 
proteins 8b and 8ab on ubiquinated proteins.   
 
4.5. Binding of proteins 8b and 8ab to interferon regulatory factor 3 
In the immunoprecipitation experiments, IRF 3 was found to bind to proteins 8b 
and 8ab. Based on the density of immunoprecipitated protein bands, it is noticed that the 
binding affinity of IRF 3 to protein 8b might be stronger than to protein 8ab.  
When host cells are infected, cells quickly produce interferons (IFNs). Newly 
synthesized IFNs will activate the innate immune systems to resist viruses (Sen, 2001). 
Most viruses including coronaviruses are known to elicit the interferon pathway, 
(Aurisicchio et.al., 2000; Levy et.al., 2001; Pei et.al., 2001; Cinatl et.al., 2003). However, 
in order to increase virus virulence, pathogenic viruses develop various mechanisms to 
down-regulate the IFN systems by interfering with IFN induction, IFN signaling or the 
action of IFN-induced effector proteins (Basler et.al., 2002). Obstructing IFN induction is 
known to be one of the most efficient mechanisms that viruses utilize to counteract the 
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IFN system. Impairment of the IFN response can cause failure of activation of the innate 
immune system (Sen, 2001). 
Unlike other coronaviruses, SARS-CoV is shown to inhibit the IFN-β producing 
process. Upon infection of SARS-CoV, no endogenous IFN-β transcripts were produced 
in infected cells (Cheung et.al., 2005). Interferon regulatory factor 3 is involved in the 
activation of IFN-β gene (Hiscott et.al., 1999; Iwamura et.al., 2001). Double strand RNA 
initiates the IFR 3 signaling pathways (Sastre, 2001). After receiving the upstream signal, 
cytosol IRF 3 is translocated to the nucleus; it is phosphorylated and homodimerizes 
(Hiscott et.al., 1999). Subsequently, the IRF 3 dimers bind to CBP (Suhara et.al., 2002). 
This complex can recognize and activate IFN-β with initiation of IFN-β transcription by 
IRF-3 (Iwamura et.al., 2001). Spiegel M. et.al 2005 found that IRF3 is translocated to the 
nucleus at early stage of SARS-CoV infection but IRF 3 is sequestered in the cytoplasm at 
late stage of infection; no phosphorylated IRF 3 homodimer is found and hence the 
impaired  IRF3 cannot form complex with CPB. The binding of proteins 8b and 8ab to 
IRF3 might be the answer for this phenomenon. It is likely that the IRF 3 interaction of 
proteins 8b and 8ab retain IRF 3 in the cytoplasm, preventing IRF 3 function. However, it 
is not clear how the binding of proteins 8b and 8ab impairs IRF 3 functioning and whether 
the binding of these proteins to ubiquitin and IRF 3 leads to the degradation of IRF3. The 
inactivation of IRF 3 function by protein 8b and 8ab inhibits the IFN response, thus 





CHAPTER 5. CONCLUSIONS AND FUTURE DIRECTIONS 
5.1. Conclusions  
This is the first attempt in trying to gain insights into translation of the subgenomic 
mRNA 8 of SARS-CoV, ever since the discovery of this virus in 2003. From the study, 
the following novel findings can be concluded:  
1. It was shown that ORFs 8a/b and 8ab expressed proteins 8a and 8ab respectively.  
2. Protein 8ab is an N-glycosylated protein. Glycomod Tool Program predicted the 
N81 residue to the site for glycosylation. The production was verified by PNGase 
F treatment and site-directed mutagenesis. 
3. As the lack of the 8a region, protein 8b is susceptible to rapid degradation. 
4. Proteins 8b and 8ab could bind both covalently and non-covalently to mono- and 
poly-ubiquitin. The ubiquitin-binding domain in these proteins could be novel 
since no homology to any known ubiquitin-binding domains was found. 
5. Ubiquitinated proteins 8b and 8ab interact with the cellular ubiquitinated proteins 
such as p53 and IκBα. This strongly suggests that ubiquination facilitated the 
interaction of proteins 8b and 8ab with other ubiquitinated protein. 
6. Proteins 8b and 8ab interact with interferon regulatory factor 3. Protein 8b binds 
more efficiently to IRF 3 than protein 8ab.  
7. Proteins 8a and 8ab are localized in the cytoplasm while protein 8b is localized in 
the ER.   
 These findings would provide new insights into pathogenesis of SARS-CoV. The 
hypotheses, herein, lay the ground for other researchers attempting to understand the 
pathogenesis and signal transduction processes in this important pathogen of human. 
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First, it is certain that SARS-CoV expresses protein 8a in infected cells. Second, in 
addition to the utilization of glycan proteins in receptor binding as well as in the 
assembly process, SARS-CoV also exploits the glycosylation process in infected cells for 
the folding proteins. Third, cytoplasmic localization of proteins 8b and 8ab and their 
interaction with IRF 3 may explain the retaining of IRF 3 in the cytoplasm, leading to 
non-functional IRF 3 upon SARS-CoV infection. Thus, proteins 8b and 8ab may regulate 
host immunoresponse to SARS-CoV. The more efficient binding of protein 8b to IRF 3 
may be attributed to the adaptation of SARS-CoV from animals to human, since most 
SARS-CoV isolated in the late outbreak stages has ORF 8b instead of ORF 8ab. Finally, 
the interaction of proteins 8b and 8ab with p53 and IκBα in the presence of ubiquitin 
indicates the involvement of the proteins in SARS-CoV pathogenesis. In addition, 
proteins 8b and 8ab might utilize their ubiquitinated forms to bind to cellular ubiquinated 
proteins and henceforth disrupt the activities of these cellular proteins.   
 Understanding the signal transduction processes involved in the pathogenesis of 
SARS-CoV should give us an insight into better vaccine or drug development and 
hopefully a better control of SARS-CoV. 
 
5.2. Future direction 
 In this study, the characteristics of these proteins were established in cells 
expressing individual proteins, but not in the context of virus-infected cells. Protein 8a 
was found to be expressed in the SARS-CoV infected cells by other groups but the 
functions of this protein need to be further elucidated. To investigate functions of protein 
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8a, a yeast two hybrid experiment may be employed to identify cellular interacting 
proteins.  
Protein 8b was not detected from ORF 8a/8b. This could be due to the lack of the 
elements of subgenomic mRNA 8 during transcription and translation. Therefore, it is 
necessary to find proper translational systems to clarify expression of ORF 8b. For 
example, the expression of protein 8b may be studied by using SARS-CoV replicon 
which contains sufficient transcription elements to produce SARS-CoV subgenomic 
mRNA. 
In this study, protein 8ab was proposed to undergo calnexin-calreticulin cycle. 
Co-immunoprecipitation experiments may be carried out to study the interaction of 
protein 8ab with calnexin. Proteins 8b and 8ab are shown to possess ubiquitin-binding 
domains and may represent a novel group of ubiquitin-binding proteins. As they could 
bind to p53 and IκBα, it would be interesting to determine the biological consequence of 
these interactions. Regulation of cellular p53 levels is one of the means many viruses use 
to increase virulence. The effect of proteins 8b and 8ab on the cellular p53 level may be 
studied by overexpression of the viral proteins in cells. Also, the significance of the 
binding of protein 8b and 8ab to ubiquitinated IκBα  may be studied by investigating the 
transcriptional regulation of cytokine and chemokine genes by NFκΒ. In addition, 
proteins 8b and 8ab were demonstrated to bind to IRF 3. Further experiments 
investigating the consequences on nuclear translocation and phosphorylation of IRF 3 in 
the presence of protein 8b and 8ab may provide further insights into the mechanism of 
IRF 3 inhibition. 
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APPENDIX. CONSTRUCTIONS OF PLASMID  
pKT0 8a/b: TRS plus ORF 8a/8b fragment from nucleotides 27752 and 28102 was 
amplified from strain SG2774 (accession No: AY283798) by PCR using TRS-8 forward 
primer (5’ GCGAATTCTCTAAACGAACATGAAAC 3’) and 8 reverse primer (5’ 
GCTCTAGATTAATTTGTTCGTTTATT 3’). The two primers were incorporated with 
EcoRI and XbaI endonuclease restriction sites, respectively. The PCR fragment was 
digested with EcoRI/XbaI and ligated into EcoRI/ XbaI digested pKT0 (Liu et.al., 1994).  
pF-8a/b: ORF 8a/8b fragment  from nucleotides 27763 and 28102  was amplified 
from p8a/b by PCR using EcoRV 8 forward primer (5’ 
GGGATATCCATGAAACTTCTCAT 3’) and 8 reverse primer. The ORF 8a/b fragment 
was digested with EcoRV and XbaI, then ligated into EcoRV/ XbaI pFlag . 
pF-8a: Similarly, 8a fragment was PCR product of pF-8a/b using T7 primer and 
BamHI 8a reverse primer (5’ CGGGATCCCTAGTGTTGTACCTTAC 3’) and then 
cloned into EcoRV/XbaI digested pFlag. 
pF-8b: Also, the two primers EcoRV 8b forward primer (5’ 
GGGATATCCATGTGCTTGAAG-3') and 8 reverse primer were used to amplified 
fragment from pF-8a/b and then cloned in pFlag..   
pF-8ab: This plasmid was cloned by two overlapping PCR. The first round of 
overlapping PCR was to get 8a plus and 8b plus fragment. The 8a plus fragment was 
amplified from pFlag 8a using T7 primer (TAATACGACTCACTATAGGG) and 
downstream 8 deletion primer (5’ 
ATTCAGGTTGGTAACCAGTAGGACAAGGATCTTCAA 3’). Also, the 8b plus 
fragment was created by using two primers upstream 8 deletion primer (5’ TAC 
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CAACCTGAATGGAATATAAGGTACAACACTAGG 3’) and 8 reverse primer. Flag 
8ab fragment was obtained in second round of PCR in which the 8a plus and 8b plus were 
used as templates together with two primers - T7 and 8 reverse primer. The T7 8ab 
fragment was digested with Bgl II/XhaI and cloned into BamHI/XhaI digested pFlag. 
pF-8abM was created by site-direct mutagenesis with a set of commentary primers 
carrying 2 nucleotide mutation. The two primers were UP primer 5' CATGCACACCTG 
ATGTTACTATCAA 3’ and DOWN primer 5’ TTGATAGTAACATCAGGTGTGCAT 
G 3’. 
pXJ/F-8a, pXJ/F-8b and pXJ/F-8ab: pF-8a, pF-8b and pF-8ab were digested with 
BamHI and XhoI and cloned into pXJ40 digested with Bgl II/ XhoI.   
pGEX-5X -1/8b and pGEX-5X-1/8ab: 8b fragment and 8ab fragment was obtained 
by PCR amplification with two primers-EcoRI forward primer: 5’ 
CCGGAATTCCATGTGCTTGAAGATCCTTGTA AGG 3’ and 8 reverse primer for  8b 
fragment and the two primers: EcoRI 8a primer: 5’ CCGGAATTCCGGATGAAA 
TTCCTC 3’ and 8 reverse primers for 8ab fragment. The two fragments were cleaved 
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